8 Fotoğraf
Prof. Dr. Doğan Uncu
Kanserde Risk Faktörleri, Cilt Kanseri, Prostat Kanseridevamı
İçerikler
Henüz Makale Yok
Bu uzmana ait henüz makale içeriği bulunmamaktadır.
Son Değerlendirme
Çok güleryuzlu ve ilgili bir doktor ona tesekkürederim.hastalıgom sirasinda bizimle...devamı
Adresler
İstinye Üniversitesi Gaziosmanpaşa HastanesiHaritada Gör
Merkez Mah. Çukurçeşme Caddesi No:51 Gaziosmanpaşa İSTANBUL
Gaziosmanpaşa/İstanbulUzmanlık Hizmetleri
- Kanserde Beslenme ve Destek Tedaviler
- Kanser Ağrı Tedavisi
- Kemoterapi (ilaçla kanser tedavisi)
- Karın içi sıcak kemoterapi (hipek)
- Nöroendokrin Tümör
- Kanser tedavisi sonrası takip
- Kanser tedavisinde akıllı ilaç tedavisi
- Serviks kanseri
- Hedefe Yönelik Tedavi (Akıllı İlaç)
- İmmünoterapi
Özgeçmiş
1998 yılında Hacettepe Üniversitesi Tıp Fakültesi’nden mezun oldu. 2002 yılında Sağlık Bakanlığı, Ankara Numune Eğitim ve Araştırma Hastanesi, 5. Dâhiliye Kliniğinde İç Hastalıkları uzmanlık eğitimini tamamladı. Takiben aynı klinikte uzman olarak görevine devam ettikten sonra, 2003 yılında yine aynı hastanede Tıbbi Onkoloji yan dal ihtisasına başladı ve 2006 yılında Tıbbi Onkoloji uzmanlık eğitimini tamamladı. 2007-2008 yıllarında 11 ay süreyle Gülhane Askeri Tıp Akademisi, Tıbbi Onkoloji Bilim Dalı’nda askerlik hizmetini yedek subay olarak yaptı. 2008 yılında Ankara Numune Eğitim ve Araştırma Hastanesi Tıbbi Onkoloji Kliniği’ne Tıbbi Onkoloji uzmanı olarak atandı. 2010 yılında Başasistan kadrosuna atandı. 2012 yılında Doçent Unvanı’nı almaya hak kazandı. 2014 yılında Tıbbi Onkoloji Eğitim Görevlisi olarak görevlendirildi. 2011-2015 yılları arasında Dahiliye Klinikleri Koordinatörlüğü görevini yaptı. 2010-2016 yılında Bilimsel Araştırmalar Değerlendirme Komisyonu sekreterya görevini yaptı. 2012-2019 yılları arasında Ankara Numune Hastanesi Klinik Araştırmalar Etik Kurul üyesi olarak görev yaptı. Mayıs 2018 tarihinde Ankara Numune SUAM Tıbbi Onkoloji Eğitim ve İdari Sorumlusu olarak görevlendirildi. Eylül 2018’de Sağlık Bilimleri Üniversitesi Ankara Numune SUAM’da Profesör kadrosuna atandı.
Ücret Bilgisi
Muayene ücretlerini öğrenmek için ara
Yorumlar
Görüşlerinizi Önemsiyoruz
Uzmanlar ile ilgili görüşlerinizi belirtmeden öncemoderasyon sürecimizhakkında daha fazlasını öğrenin.
5.0
★★★★★
Toplam 1 değerlendirmeZamanlama5.0
İlgi5.0
Ortam5.0
P
P*** C***06.07.2019
Zamanlama
★★★★★
5.0İlgi
★★★★★
5.0Ortam
★★★★★
5.0Çok güleryuzlu ve ilgili bir doktor ona tesekkürederim.hastalıgom sirasinda bizimle cok ilgilenmistir
Mesleki Bilgiler
Deneyim Süresi
Ocak 1998 - Günümüz (28 yıl)
28 yıllık mesleki deneyim
Diploma Aldığı Kurum
Hacettepe Üniversitesi Tıp Fakültesi
Uzmanlık Aldığı Kurum
Ankara Numune Eğitim Ve Araştırma Hastanesi
Deneyimler
Sağlık Bilimleri Üniversitesi Ankara Bilkent Şehir Hastanesi Tıbbi Onkoloji Eğitim ve İdari Sorumlusu
Yabancı Diller
İngilizce
Yayınlar
A. Uluslararası hakemli dergilerde yayımlanan makaleler:
A1. Ozberk U, Esen SA, Sekmek S, Seven I, Bal O, Algin E, Yucel S, Uncu D, Anticancer, Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity, Drugs, doi: 10.1097/CAD.0000000000001798, 2025
A2. Doğan Bayram, Efe Cem Erdat, Sema Nur Özsan Çelebi, Serap Türk, Serhat Sekmek, Perihan Perkin, Selin Aktürk Esen, Gökhan Uçar, Mehmet Ali Nahit Şendur, Doğan Uncu, Fahriye Tuğba Köş, Burak Civelek, The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study, Journal of Hepatocellular Carcinoma, 12:2811-2823, 2025
A3. Seven İsmet, Karahan İrfan,Köş Fahriye Tuğba, Sekmek Serhat, Bayram Doğan, Uçar Gökhan, Uncu Doğan, Clinicopathological features of the patients with human epidermal growth factor receptor immunohistochemistry 2+ early stage breast cancer. Annals of Clinical and Analytical Medicine, Doi: 10.4328/ACAM.22464, 2025
A4. Majıdova Nargız, Arpacı Erkan, Akıncı Muhammed Bülent, Uncu Doğan, Uçar Gökhan, Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study. Journal of Clinical Medicine, 14, Doi: 10.3390/jcm14124189, 2025
A5. Sekmek Serhat, Mehtiyev Mirmehdi, Bayram Doğan, Uçar Gökhan, Bal Öznur, Algın Efnan, Köş Fahriye Tuğba, Civelek Burak, Uncu Doğan, CDK4-6 Inhibitors: Evaluation of Efficacy in Cases of Hormone Receptor-Positive HER2-Negative Breast Cancer with Only Bone Metastas.is Journal of Oncological Sciences, 11, Doi: 10.37047/jos.galenos.2024.2024.103871, 2025
A6. Bayram D, Efil SC, Türk S, Kara O, Sekmek S, Yücel Ş, Aktürk Esen S, Uçar G, Bal O, Algin E, Uncu D. Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma. Clin Med Insights Oncol. 2025 Oct 17;19
A7. Hafızoğlu E, Bardakçı M, Ergun Y, Karahan I, Bayram D, Kos FT, Algın E, Bal O, Uncu D. Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis. Diagnostics (Basel). 2025 Aug 20;15(16):2086.
A8. Seven İ, Çalişkan C, Köş FT, Arslan H, Aktürk Esen S, Ceylan F, Uncu D. Predicting survival outcomes in advanced pancreatic cancer using machine learning methods. Medicine (Baltimore). 2025 Aug 15;104(33):e43904.
A9. Seven İ, Karacan MA, Çelebi SÖ, Karahan İ, Kapanşahin K, Köş FT, Özdemir E, Uncu D. The predictive value of sarcopenia and PET imaging metrics in metastatic non-squamous NSCLC. Biomark Med. 2025 Aug;19(15):707-716.
A10. Ceylan F, Şener Dede D, Efil SC, Tenekeci AK, Ceylan EG, Sekmek S, Çakmak M, Bilgin B, Yücel Ş, Tatli Doğan H, Şendur MAN, Akinci MB, Uncu D, Yalçin B. Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer. Turk J Med Sci. 2025 Jun 2;55(3):547-558.
A11. Karabuğa B, Büyükkör M, Karabuğa EK, Yıldız S, Mehtiyev M, Çınkır HY, Koçoğlu SS, Demir H, Yazıcı O, Uncu D, Öksüzoğlu ÖB, Yalçıntaş Arslan Ü. Illuminating Bilateral Breast Cancer: A Multicenter Experience and Clinical Observations. Medicina (Kaunas). 2025 Jun 1;61(6):1029.
A12. Sekmek S, Oguz A, Karakurt Eryilmaz M, Araz M, Biter S, Kıdı MM, Bayram E, Erdat EC, Yasar A, Colak R, Yilmaz M, Bakir Kahveci G, Divriklioglu D, Chalabiyev E, Aksoy S, Ozsan Celebi SN, Kosku H, Yılmaz M, Hacibekiroglu I, Temizyurek H, Canaslan K, Turhan G, Kadıoglu A, Jeral S, Atak M, Atacan H, Ozbay A, Atasever T, Seyyar M, Can Sanci P, Koylu B, Majidova N, Arpaci E, Akinci MB, Uncu D, Ucar G. Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study. J Clin Med. 2025 Jun 12;14(12):4189.
A13. Hasturk D, Akturk Esen S, Sahiner ES, Erel O, Neselioglu S, Aydogan N, Buyukaksoy M, Seven I, Yucel S, Uncu D. Thiol-disulfide homeostasis and ischemia modified albumin levels in patients diagnosed with ovary carcinoma. Sci Rep. 2025 Jun 5;15(1):19729.
A14. Ceylan F, Aktürk Esen S, Ünal OÜ, Aslan F, Onur İD, Ateş Ö, Demirciler E, Ünek İT, Gülmez A, Özen Engin E, Taş S, Gököz Doğu G, Şimşek M, Türk HM, İnal A, Şahin G, Yüksel HÇ, Tenekeci AK, Hızal M, Şendur MAN, Uncu D. Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study. Medicina (Kaunas). 2025 Apr 22;61(5):776.
A15. Kalkan NO, Ucar G, Esen SA, Bardakci M, Aydin SG, Celebi A, Simsek M, İleri S, Avci O, Akdağ G, Arici MO, Hendem E, Ak N, Yildirim O, Aykan NF, Uncu D, Sendur M, Olmez OF, Bilici A, Kostek O, Turk HM, Urakci Z, Dogan M, Karacin C, Bilen E, Ergun Y. Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis. Niger J Clin Pract. 2025 Feb 1;28(2):212-218.
A16. Hafızoğlu E, Bardakçı M, Ergun Y, Karahan I, Demirtaş Esmer D, Bayram D, Kos FT, Algın E, Bal O, Uncu D. Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective Cohort. Medicina (Kaunas). 2025 Apr 14;61(4):724.
A17. Bayram D, Bal Ö, Karaman K, Bardakçı M, Demirtaş Esmer D, Seven İ, Sekmek S, Perkin P, Köş FT, Algın E, Uncu D. A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score.Curr Oncol. 2025 Mar 28;32(4):200.
A18. Özdemir H, Demir A, Bardakçı M, Uncu D. The effect of an interactive nurse support program developed with a mobile application on patient outcomes in breast cancer patients who received outpatient chemotherapy: A randomized controlled trial. Eur J Oncol Nurs. 2025 Jun;76:102882.
A19. Akturk Esen S, Seven I, Akdere Ates G, Colak R, Kinikoglu O, Akay Hacan B, Bakkal Temi Y, Sever N, Kahraman S, Arak H, Topcu A, Saray S, Akbas S, Beypinar İ, Acar O, Erdoğan AP, Yilmaz M, Isik D, Ates O, Cabuk D, Sendur MAN, Uncu D. Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study. Anticancer Drugs. 2025 Aug 1;36(7):575-582.
A20. Seven İ, Bayram D, Arslan H, Köş FT, Gümüşlü K, Aktürk Esen S, Şahin M, Şendur MAN, Uncu D. Predicting hepatocellular carcinoma survival with artificial intelligence. Sci Rep. 2025 Feb 20;15(1):6226.
A21. Kos FT, Cecen Kaynak S, Aktürk Esen S, Arslan H, Uncu D. Comparison of Different Machine Learning Models for Predicting Long-Term Overall Survival in Non-metastatic Colorectal Cancers. Cureus. 2024 Dec 14;16(12):e75713.
A22. Ceylan F, Mehdiyev M, Dede DŞ, Efil SC, Tenekeci AK, Bilgin B, Yücel Ş, Tatlı Doğan H, Şendur MAN, Akıncı MB, Uncu D, Yalçın B. Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer. J Clin Med. 2024 Dec 31;14(1):173.
A23. Mete Civelek G, Borman P, Sahbaz Pirincci C, Yaman A, Ucar G, Uncu D, Kahraman S, Dalyan M. The Comparative Frequency of Breast Cancer-Related Lymphedema Determined by Perometer and Circumferential Measurements: Relationship with Functional Status and Quality of Life. Lymphat Res Biol. 2025 Apr;23(2):88-94.
A24. Seven İ, Köş FT, Tatli Doğan H, Kişlal MH, Sekmek S, Karahan İ, Aktürk Esen S, Uncu D. A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinib. Anticancer Drugs. 2025 Feb 1;36(2):151-153.
A25. Seven İ, Aktürk Esen S, Sekmek S, Karahan İ, Büyükaksoy M, Kökenek Ünal TD, Uncu D. Clinicopathological features and treatment outcomes of urothelial carcinoma variant histologies and non-urothelial bladder cancers. Int Urol Nephrol. 2025 May;57(5):1451-1463.
A26. Urakçı Z, Kaplan MA, Oruç Z, Gümüş M, Uncu D, Ebinç S, Özkan M, Geredeli Ç, Elkıran ET, Girgin S. Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast Cancer. Ann Ital Chir. 2024;95(6):1170-1177.
A27. Sekmek S, Bayram D, Karahan I, Seven I, Perkin P, Muftuoglu KH, Bal O, Yalcin B, Uncu D, Algin E. Prognostic Significance of HER2 Positivity in Endometrium Cancer. Oncol Res Treat. 2025;48(3):75-81.
A28. Bayram D, Sekmek S, Kayaalp M, Bardakçı M, Hafızoğlu E, Uçar G, Algin E, Bal O, Civelek B, Şendur MAN, Kos FT, Uncu D. Clinical features and prognostic factors in thymoma and thymic carcinoma. Indian J Thorac Cardiovasc Surg. 2024 Nov;40(6):660-668.
A29. Ureyen I, Toptas T, Tokalıoğlu A, Sahin M, Oktar O, Kole M, Alcı A, Ozturk C, Ozmen F, Akturk SE, Erdogan O, Ersak B, Kilic F, Bas S, Cakir C, Kocak O, Kilic Ç, Ucar G, Korkmaz V, Narin MA, Uncu D, Sanci M, Kimyon Comert G, Ozdal B, Tekin Moralıoglu O, Engin Ustun Y, Boran N, Taskin S, Tasci T, Ortac F, Turan T. Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study. Arch Gynecol Obstet. 2024 Oct;310(4):2167-2171.
A30. Ilhan Y, Ucar G, Baser MN, Guzel HG, Efil SC, Demir B, Ercan Uzundal D, Karacelik T, Sever N, Balcik OY, Arvas H, Karadag I, Kadioglu A, Ekinci ÖB, Karacin C, Urakci Z, Kostek O, Karakurt Eryilmaz M, Yazici O, Sendur MAN, Ozturk B, Uncu D, Ergun Y. Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert Opin Pharmacother. 2024 Aug;25(11):1555-1563.
A31. Uçar G, Sekmek S, Karahan İ, Ergün Y, İsak ÖA, Tunç S, Doğan M, Gürler F, Bayram D, Açıkgöz Y, Esen SA, Civelek B, Köş FT, Bal Ö, Algın E, Eren T, İmamoğlu Gİ, Urakçı Z, Yazıcı O, Özdemir N, Uncu D. The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer. Oncology. 2025;103(2):128-133.
A32. Bardakçi M, Algin E, Düğeroğlu B, Bal Ö, Köş FT, Uncu D. Management and prognosis of patients with cancer of unknown primary: 20 years of experience.Turk J Med Sci. 2023 Nov 11;53(6):1722-1731.
A33. Hasturk D, Akturk Esen S, Buyukaksoy M, Civelek B, Seven I, Uncu D. Primary colon lymphomas: An analysis of our experience over the last 18 years. Medicine (Baltimore). 2024 May 10;103(19):e38013.
A34. Aktürk Esen S, Karabulut S, Buyukaksoy M, Kurt Cevik G, Ceylan F, Civelek B, Şendur MAN, Erdogan F, Uncu D. Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer? Medicine (Baltimore). 2024 Mar 29;103(13):e37656.
A35. Gürler F, Aktürk Esen S, Kurt İnci B, Sütçüoğlu O, Uçar G, Akdoğan O, Uncu D, Turhan N, Akyürek N, Özdemir N, Özet A, Yazıcı O. Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer Invest. 2024 Feb;42(2):141-154.
A36. Sekmek S, Karahan I, Ucar G, Ceylan F, Bayram D, Seven I, Bölek H, Ürün Y, Yücel KB, Yazici O, Kadioglu A, Karacin C, Canaslan K, Atag E, Demirer S, Erdem GU, Ergun Y, Atak M, Koksal B, Kiran MM, Turkay DO, Civelek B, Yalcin B, Uncu D. Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study. Clin Transl Oncol. 2024 Aug;26(8):1878-1885.
A37. Karacin C, Sunar V, Urakci Z, Yilmaz A, Ayhan M, Ersoy M, Guven DC, Erturk I, Durmus Y, Karacin P, Boran N, Ustun YE, Meydan M, Dogan M, Oksuzoğlu B, Ates O, Karaca M, Uncu D, Ergun Y, Arik Z. Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.Future Oncol. 2024 Feb;20(4):207-214.
A38. Tokalioglu AA, Oktar O, Sahin M, Ozturk C, Erdogan O, Yildirim HEK, Ucar Y, Kilic F, Ersak B, Yalcin N, Ozmen F, Alci A, Bas S, Gorgulu G, Selcuk I, Ucar G, Kocak O, Cakir C, Kilic C, Comert GK, Ureyen I, Toptas T, Narin MA, Tasci T, Taskin S, Boran N, Ozdal B, Sanci M, Uncu D, Korkmaz V, Tekin OM, Ustun Y, Ortac F, Turan T. Defining the relationship between ovarian adult granulosa cell tumors and synchronous endometrial pathology: Does ovarian tumor size correlate with endometrial cancer? J Obstet Gynaecol Res. 2024 Apr;50(4):655-662.
A39. Akturk Esen S, Uncu D. Is the watch-and-wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer? J Surg Oncol. 2024 Mar;129(3):459-460.
A40. Sekmek S, Bayram D, Ucar G, Civelek B, Kos FT, Uncu D. Cabozantinib-induced heart failure. J Oncol Pharm Pract. 2024 Jan;30(1):225-227.
A41. Acikgoz Y, Yildirim FU, Esen SA, Ucar G, Ergun Y, Bal O, Dogan M, Uncu D. The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer. Am J Clin Oncol. 2023 Dec 1;46(12):543-550.
A42. Bardakci M, Esmer DD, Hafizoglu E, Karaman K, Kuzu OF, Karakas H, Gungorer B, Uncu D. Evaluation of clinical and prognostic factors for primary gastric diffuse large B-cell lymphoma: Single-center experience. J Cancer Res Ther. 2023 Apr-Jun;19(3):778-782.
A43. Erdogan O, Kilic C, Cakir C, Kilic F, Oktar O, Ersak B, Sahin M, Tokalioglu A, Kocak O, Ozturk C, Gorgulu G, Gokkaya M, Selcuk I, Korkmaz V, Comert GK, Toptas T, Ureyen I, Ucar G, Taskin S, Tasci T, Uncu D, Narin MA, Boran N, Ozdal B, Tekin OM, Ustun Y, Sancı M, Ortac F, Turan T. Is adjuvant chemotherapy necessary for 2014 FIGO stage IC adult granulosa cell tumor?: Multicentric Turkish study. Asia Pac J Clin Oncol. 2024 Feb;20(1):46-54.
A44. Akdeniz N, Kaplan MA, İnanç M, Uncu D, Ergün Y, Küçüköner M, Demirci A, Şendur MAN, Beşiroğlu M, Topçu A, Yerlikaya H, Urakçi Z, Kiliçkap S, Işikdoğan A. The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study. Pancreas. 2022 Oct 1;51(9):1153-1159.
A45. Akturk Esen S, Ozgun YM, Hasturk D, Ucar G, Bostanci EB, Sendur MAN, Uncu D. Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer. Oncology. 2023;101(5):321-327.
A46. Sekmek Serhat, Uçar Gökhan, Karahan İrfan, Bayram Doğan, Aktürk Esen Selin, Seven İsmet, Şendur Mehmet Ali Nahit, Uncu Doğan (2023). Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer. African Journal of Urology, 29(66),
A47. Ergün Yakup, Aktürk Esen Selin, Bardakçı Murat, Uçar Gökhan, Kalkan Ziya, Urakçı Zuhat, Şeyran Erdoğan, Doğan Mutlu, Eren Tülay, Aslan Volkan, Kahraman Seda, Genç Emine Eylem, Açıkgöz Yusuf, Dirikoç Merve, Esen İrfan, Uncu Doğan (2022). Predictive And Prognostic Effect Of ABO Blood Group On İmmune Checkpoint İnhibitors. Cancer Biomarkers, 34(2), 329-336
A48. Aktürk Esen Selin, Fırat Oğuz Esra, Ergün Yakup, Hastürk Denizcan, Bardakçı Murat, Uçar Gökhan, Şendur Mehmet Ali Nahit, Ateş İhsan, Erel Özcan, Uncu Doğan (2022). Ischemia-Modified Albumin and Thiol -Disulfide Homeostasis in Metastatic Pancreatic Cancer. Journal of Oncological Sciences, 8(3), 148-156.
A49. Erol C, Sendur MAN, Bilgetekin I, Garbioglu DB, Hamdard J, Akbas S, Hizal M, Arslan C, Sevinc A, Kucukarda A, Erdem D, Kahraman S, Cakir E, Demirkiran A, On S, Dogan I, Erdogan AP, Koca S, Kubilay P, Eren OO, Cilbir E, Celik E, Araz M, Ozyukseler DT, Yildirim ME, Bahceci A, Taskaynatan H, Oyman A, Deniz GI, Menekse S, Kut E, Gulmez A, Sakin A, Nayir E, Acar R, Sen E, Inal A, Turhal S, Kaya AO, Paydas S, Tastekin D, Hacibekiroglu I, Cincin I, Bilici A, Mandel NM, Dede DS, Akinci MB, Oksuzoglu B, Uncu D, Yalcin B, Artac M. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group. J Cancer Res Ther. 2022 Dec;18(12 Suppl 2):S347-S353.
A50. Aktürk Esen S, Ergun Y, Erol C, Arikan R, Er MM, Atci MM, Topçu A, Uçar G, Akagündüz B, Aykan MB, Özen M, Baytemur NK, Özçelik M, Şahin E, Güven D, Menekşe S, Ak N, Teker F, Kut E, Şakalar T, Alan Ö, Kaçan T, Turhal NS, Kiliçkap S, Türker S, Şendur MAN, Köstek O, Karaağaç M, Sakin A, Türk HM, Çağlayan D, Cihan Ş, Açikgöz Y, Uncu D. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer. Bosn J Basic Med Sci. 2022 Sep 16;22(5):818-825.
A51. Ergun Y, Esen SA, Bardakci M, Ucar G, Kalkan Z, Urakci Z, Seyran E, Dogan M, Eren T, Aslan V, Kahraman S, Genc EE, Acikgoz Y, Dirikoc M, Esen I, Uncu D. Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors. Cancer Biomark. 2022;34(2):329-336.
A52. Bardakci M, Hafizoglu E, Kos FT, Uncu D. Does Prognostic Nutritional Index Predict Survival in Operated Papilla Vateri Tumors? A Single-centre Experience. J Coll Physicians Surg Pak. 2021 Dec;31(12):1428-1432.
A53. Sütcüoğlu O, İlhan A, Tacar SY, Güven DC, Uçar G, Karadurmuş N, Yıldız F, Eraslan E, Uncu D, Tural D, Üner A, Günel N, Özdemir N, Kılıçkap S, Öksüzoğlu ÖB, Özet A, Yazıcı O. Thirty-day mortality rates after immunotherapy initiation. Immunotherapy. 2021 Dec;13(17):1419-1426.
A54. Ates O, Oksuzoglu OB, Aktas BY, Karadag I, Esen S, Karakaya S, Uncu D, Erol C, Gurbuz M, Yalcin B, Aksoy S. Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data. J BUON. 2021 Jul-Aug;26(4):1398-1404
A55. Atabilen B, Akbulut G, Bacanli M, Uncu D. Is the nuclear factor kappa-b (NF-κB) pathway and inflammatory status associated with colorectal cancer? Saudi J Gastroenterol. 2022 Jan-Feb;28(1):60-66.
A56. Karacin C, Eren T, Zeynelgil E, Imamoglu GI, Altinbas M, Karadag I, Basal FB, Bilgetekin I, Sutcuoglu O, Yazici O, Ozdemir N, Ozet A, Yildiz Y, Esen SA, Ucar G, Uncu D, Dinc B, Aykan MB, Erturk İ, Karadurmus N, Civelek B, Çelik İ, Ergun Y, Dogan M, Oksuzoglu OB. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Future Oncol. 2021 Nov;17(33):4447-4456.
A57. Acikgoz Y, Aktürk Esen S, Ucar G, Dirikoc M, Ergun Y, Bal O, Uncu D. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer. Cureus. 2021 May 7;13(5):e14882.
A58. Coskun N, Okudan B, Uncu D, Kitapci MT. Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma. Nucl Med Commun. 2021 Nov 1;42(11):1227-1232.
A59. NazimTurhal S, Dogan M, Esendagli G, Artac M, Korkmaz L, Coskun HS, Goker E, PerranYumuk F, Bilgetekin I, Kose F, Uncu D, Kavgaci H, Akyol G, Ozet A, Yagci T. The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study. J Gastrointest Cancer. 2022 Jun;53(2):356-362.
A60. Akdeniz N, Kaplan MA, Uncu D, İnanç M, Kaya S, Dane F, Küçüköner M, Demirci A, Bilici M, Durnalı AG, Koral L, Şendur MAN, Erol C, Türkmen E, Ölmez ÖF, Açıkgöz Ö, Laçin Ş, Şahinli H, Urakçı Z, Işıkdoğan A. The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study. Int J Colorectal Dis. 2021 Jun;36(6):1311-1319.
A61. Esen SA, Acikgoz Y, Bal O, Yildiz B, Ucar G, Dirikoc M, Ergun Y, Algin E, Uncu D. A Comparison of Osseous and Extraosseous Ewing Sarcoma. J Coll Physicians Surg Pak. 2021 Jan;31(1):27-33.
A62. Gürbüz M, Akkuş E, Sakin A, Urvay S, Demiray AG, Şahin S, Şakalar T, Erol C, Şendur MAN, Şahin AB, Çubukçu E, Güven DC, Kılıçkap S, Ergün Y, Uncu D, Turhal NS, Üskent N, Çınkır HY, Demir A, Acar R, Karadurmuş N, Türker S, Altınbaş M, Karaoğlan M, Şenler FÇ. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group. J Gastrointest Cancer. 2022 Jun;53(2):282-288.
A63. Yüksel D, Ayhan S, Korkmaz V, Çakır C, Kılıç Ç, Akgor U, Özgül N, Kılıç F, Ersak B, Esen S, Kuru O, Uncu D, Gökcü M, Özdal B, Gültekin M, Salman MC, Boran N, Toptaş T, Üreyen I, Taşcı T, Kimyon Cömert G, Türkmen O, Moraloğlu Tekin Ö, Engin Üstün Y, Turan T. Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15-39 Years: A Turkish Multicenter Study. J Adolesc Young Adult Oncol. 2021 Dec;10(6):697-702.
A64. Açikgoz Y, Gurler F, Inci BK, Ergun Y, Ucar G, Dirikoc M, Esen SA, Tekin BO, Bal O, Dogan M, Uncu D. The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer. Medicine (Baltimore). 2020 Nov 25;99(48):e23168.
A65. Gürbüz M, Akkuş E, Sakin A, Urvay S, Demiray AG, Şahin S, Şakalar T, Erol C, Şendur MAN, Şahin AB, Çubukçu E, Güven DC, Kılıçkap S, Ergün Y, Uncu D, Turhal NS, Üskent N, Yeşil Çınkır H, Demir A, Acar R, Karadurmuş N, Türker S, Altınbaş M, Karaoğlan M, Çay Şenler F. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer. Tumori. 2021 Oct;107(5):416-423.
A66. Ucar G, Acikgoz Y, Ergun Y, Bal O, Yilmaz M, Karakaya S, Akdeniz N, Kostek O, Aydin Isak O, Yazici Sener G, Dirikoc M, Aktürk Esen S, Dogan M, Uncu D. Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? Cureus. 2020 Sep 18;12(9):e10525.
A67. Ucar G, Acikgoz Y, Ergun Y, Eren T, Dirikoc M, Esen SA, Yazıcı O, Uncu D, Ozdemir NY.J Prognostic and Predictive Value of NAR Score in Gastric Cancer. Gastrointest Cancer. 2021 Sep;52(3):1054-1060.
A68. Yüksel Dilek, Ayhan Sevgi, Korkmaz Vakkas, Çakır Caner, Kılıç Çiğdem, Akgör Utku, Özgül Nejat, Kılıç Fatih, Ersak Burak, Aktürk Esen Selin, Kuru Oğuzhan, Uncu Doğan, Gökcü Mehmet, Özdal Bülent, Gültekin Murat, Salman Mehmet Coşkun, Boran Nurettin, Toptaş Tayfun, Üreyen Işın, Taşçı Tolga, Kimyon Cömert Günsu, Türkmen Osman, Moraloğlu Tekin Özlem, Engin Üstün Yaprak, Turan Ahmet Taner (2021). Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15–39 Years: A Turkish Multicenter Study. Journal of Adolescent And Young Adult Oncology, 10(6), 697-702.
A69. Ateş Öztürk, Öksüzoğlu Berna, Aktaş Burak Yasin, Karadağ İbrahim, Aktürk Esen Selin, Karakaya Serdar, Uncu Doğan, Erol Cihan, Gürbüz Mustafa, Yalçın Bülent, Aksoy Sercan (2021). Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data. Journal of BUON, 26(4), 1398-1404.
A70. Aktürk Esen Selin, Açıkgöz Yusuf, Yıldırım Mustafa, Uçar Gökhan, Ergün Yakup, Dirikoç Merve, Bal Öznur, Algın Efnan, Esen İrfan, Uncu Doğan (2021). Anxiety, Insomnia and Pandemic Awareness of Cancer Patients Receiving Chemotherapy During the COVID-19 Pandemic Period. International Journal of Hematology and Oncology, 31(3), 161-169
A71. Açıkgöz Yusuf, Güler Fatih, Kurt İnci Bediz, Ergün Yakup, Uçar Gökhan, Dirikoç Merve, Aktürk Esen Selin, Okudan Tekin Berna, Bal Öznur, Doğan Mutlu, Uncu Doğan (2020). The Prognostic Value Of Tumor/Lymph Node Standardized Uptake Value Max Ratio And Correlation With Hematologic Parameters İn Stage III Nonsmall Cell Lung Cancer. Medicine, 99(48), 23168-23168.
A72. Gönderen Çakmak HS, Uncu D. Relationship between Health Literacy and Medication Adherence of Turkish Cancer Patients Receiving Oral Chemotherapy. Asia Pac J Oncol Nurs. 2020 Sep 14;7(4):365-369.
A73. Ucar G, Ergun Y, Aktürk Esen S, Acikgoz Y, Dirikoc M, Esen İ, Bal Ö, Uncu D. Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer. Medicine (Baltimore). 2020 Sep 25;99(39):e22407.
A74. Eravcı FC, Uçar G, Özcan KM, Çolak M, Ergün Y, Açıkgöz Y, Ikincioğulları A, Uncu D, Dere HH. The effect of chemotherapy on olfactory function and mucociliary clearance. Support Care Cancer. 2021 Mar;29(3):1635-1641.
A75. Ucar G, Ergun Y, Acikgoz Y, Uncu D. The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer. Asia Pac J Clin Oncol. 2020 Oct;16(5):e179-e184.
A76. Ergun Y, Bal O, Dogan M, Ucar G, Dirikoc M, Acikgoz Y, Bacaksiz F, Uncu D. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?, J Res Med Sci. 2020 Feb 20;25:14
A77. Fahriye Tugba Kos, Sercan Aksoy, Murat Vural, Ozan Yazici, Burak Civelek, Zafer Arik, Dogan Uncu, Nuriye Ozdemir, Assessment of Endothelial Function by Flow-mediated Dilation in Patients Treated with Bevacizumab, Wulfenia Journal Klagenfurt, Vol 26, No. 3; 100-114, 2019
A78. Ergun, Y., O. Bal, M. Dogan, D. Uncu, “Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer?”,JBUON 2019, 24(6): 2435-2441, 2019
A79. Ergun Y, Y. Acikgoz, O. Bal, G. Ucar, M. Dirikoc, E. Caliskan, N. Akdeniz, D.Uncu, “KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer”, Expert Rev Mol Diagn, 19(12):1131-1140, 2019
A80. Ergün, Y., N. Ozdemir, Ş. Toptas, A. Kurtipek, T. Eren, O. Yazici, MA. Sendur, B. Akinci, G. Ucar, B. Oksuzoglu, D.Uncu, “Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study”, J BUON, 24(4):1719-1726, 2019
A81. Erdem, GU., M. Dogan, A. Sakin, Z. Oruç, E. Yaman, H.Y. Cinkir, M. Uysal, O. Bozkurt, B. Öztürk, A. Aytekin, M. Özçelik, A. Bahçeci, U. Çakıroglu, S. Turhal, S. Şahin, D. Uncu, N. Zengin, “Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder”, Oncol Res Treat, 41, 220-225, 2018, doi: 10.1159/000486598
A82. Sevinc, A., M. Ozkan, A. Ozet, F. Dane, B. Oksuzoglu, A. Isikdogan, F. Ozdemir, D. Uncu, M. Gumus, T. Evrensel, A. Yaren, O. Kara, S.B. Tekin, “Biosimilar filgrastim vs filgrastim: A multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia”, Onco Targets Ther, 11, 419-426, 2018, doi: 10.2147/OTT.S106342
A83. Ergün, Y., D. Uncu, O. Yazıcı, G. Uçar, E. Karaburga, N. Zengin, “Gastric cancer patients with bone marrow metastasis: A single-enter experience and review of the literature”, EJMO, 1, 160-163, 2017
A84. Bozkaya, Y., D. Uncu, S. Dağdaş, G.U. Erdem, M. Dogan, G. Ozet, N. Zengin, “Evaluation of Lymphoma Patients Receiving High-Dose Therapy and Autologous Stem Cell Transplantation: Experience of a Single Center”, Indian J Hematol Blood Transfus, 33(3), 361-369, 2017 doi:10.1007/s12288-016-0756-x
A85. Kos, M., C. Hocazade, F.T. Kos, D. Uncu, E. Karakas, M. Dogan, H.G. Uncu, N. Ozdemir, N. Zengin, “Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients”, Contemp Oncol (Pozn), 20, 153-157, 2016 doi: 10.5114/wo.2016.60072.
A86. Civelek, B., S. Aksoy, T. Kos, Z. Arık, M.B. Akıncı, D. Uncu, N. Özdemir, S. Cihan, N. Zengin, “Duodenal adenocarcinoma: A rare cause of chyloperitoneum (chylous ascites)”, Indian J Cancer, 52, 109, 2015
A87. Kos, F.T., C. Hocazade, M. Kos, D. Uncu, E. Karakas, M. Dogan, H.G. Uncu, N. Ozdemir, N. Zengin, “Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer”, Asian Pac J Cancer Prev, 16, 3997-4002, 2015
A88. Uncu, D., I.V. Bayoglu, U.Y. Arslan, M. Kucukoner, M. Artac, D. Koca, A. Oguz, U. Demirci, E. Arpaci, M. Dogan, Y. Kucukzeybek, I. Turker, A. Isikdogan, T. Guler, N. Zengin, “Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study”, Asian Pac J Cancer Prev, 16, 4127-4131, 2015
A89. Kos, M., C. Hocazade, F.T. Kos, D. Uncu, E. Karakas, M. Dogan, H.G. Uncu, N. Yildirim, N. Zengin, “Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer”, Wien Klin Wochenschr, 128, 635-640, 2016
A90. Civelek, B., S. Aksoy, M.A. Sendur, O. Yazici, H. Kanmaz, F.T. Kos, N. Yildirim, D.Uncu, N. Zengin, “Adjuvant chemotherapy outcomes in patients over 65 years with early stage colorectal carcinoma”, J BUON, 19, 906-912, 2014
A91. Mehmet, K., C. Sener, U. Uyetürk, M. Seker, D. Tastekin, O. Tonyali, O. Balakan, O.K. Yazici, Z. Urakci, A. Isikdogan, N. Ozdemir, A. Inal, M.A. Kaplan, A. Suner, S. Dal, D. Uncu, M. Gumus, M.C. Boruban, B. Oksuzoglu, O. Ayyildiz, M. Benekli, “Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology”, Contemp Oncol (Pozn), 18, 273-278, 2014
A92. Dogan, M., G. Utkan, C. Hocazade, D. Uncu, S. Toptas, N. Ozdemir, N. Zengin, F. Icli, “The clinicopathological characteristics with long-term outcomes in malignant mesothelioma”, Med Oncol, 31, 232, 2014
A93. Bozkurt, O., M. Inanc, I. Hacibekıroglu, O. Esbah, M. Seker, A. Ulas, K. Aydin, M. Uysal, M. Kücüköner, D. Uncu, A. Cıltas, O.Ü. Unal, A. Durnali, U. Demırcı, V. Berk, O. Tonyali, B. Oksüzoglu, H. Karaca, M. Ozkan, “Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO)”, Anticancer Res, 34, 4463-4470, 2014
A94. O.U., Unal, I. Oztop, O. Yazici, T. Ozatli, A. Inal, Y. Günaydın, S. Alici, U. Demirci, H.Y. Cinkir, B. Aktas, K. Aslan, D. Uncu, A.U. Yilmaz, B. Oksuzoglu, S. Buyukberber, “Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)”,Oncol Res Treat, 37, 332-338, 2014
A95. Seker, M.M., A. Seker, S. Aksoy, N. Ozdemir, D. Uncu, N, Zengin, “Clinicopathologic features and prognosis of osteosarcoma in Turkish adults”, Asian Pac J Cancer Prev, 15, 3537-3540, 2014
A96. Tas, D., D. Uncu, M.A., Sendur, N. Koca, N. Zengin, “Acupuncture as a complementary treatment for cancer patients receiving chemotherapy”, Asian Pac J Cancer Prev, 15, 3139-3144, 2014
A97. Akmangit, I., D. Dede, E. Daglıoglu, B, Sayın, A. Peker, D. Uncu, N. Zengin, “A Comparative Study of Low-Profile and Regular Type Totally Implantable Venous Access Devices in Patients with Malignant Tumors: Retrospective Analysis of 4501 Implantations”, Int J Hematol Oncol, 24, 97-105, 2014
A98. Sendur, M.A., S. Aksoy, N.Y. Ozdemir, S. Yaman, O. Yazici, M.B. Akinci, D. Uncu, N. Zengin, K. Altundag, “Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancer”, J BUON, 19, 115-123, 2014
A99. Sendur, M.A., D. Uncu, N. Zengin, “Longest progression-free survival with lapatinib and capecitabine combination followed by trastuzumab in HER2-positive brain metastatic breast cancer”, Med Oncol, 31, 890, 2014
A100. Seker, M.M., T. Kos, N. Ozdemir, A. Seker, S. Aksoy, D. Uncu, N. Zengin, “Treatment and outcomes of ewing sarcoma in Turkish adults: a single centre experience”, Asian Pac J Cancer Prev, 15, 327-330, 2014
A101. Kos, F.T., O. Yazici, B. Civelek, M. Seker, Z. Arik, S. Aksoy, D. Uncu, N. Ozdemir, N. Zengin, “Evaluation of the effect of comorbidity on tygsurvival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale", Wien Klin Wochenschr, 126, 36-41, 2014
A102. Açıkgöz, Y., M.A. Sendur, N.Y. Ozdemir, S. Aksoy, D. Uncu, N. Zengin, “Longest survival of lung metastatic ameloblastoma with a rare cause of malignant hypercalcemia”, J Craniomaxillofac Surg, 42, 277-278, 2014
A103. Cetin, B., M. Benekli, I. Turker, L. Koral, A. Ulas, F. Dane, B. Oksuzoglu, M.A. Kaplan, D. Koca, C. Boruban, B. Yilmaz, A. Sevinc, V. Berk, D. Uncu, H. Harputluoglu, U. Coskun, S. Buyukberber, “Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)”, J Chemother, 26, 300-305, 2014
A104. Seker, M., S. Aksoy, N.Y. Ozdemir, D. Uncu, N. Zengin, “Clinicopathologic features of gastric cancer in young patients”, Saudi J Gastroenterol, 19, 258-261, 2013
A105. Yazici, O., S. Aksoy, O. Ucar, N. Ozdemir, M. Demir, M.A. Sendur, Z. Arik, S. Yaman, T. Eren, D. Uncu, N. Zengin, “Arrhythmias during and after zoledronic acid infusion patients with bone metastasis”, Med Oncol, 30, 609, 2013
A106. Sendur, M.A., S. Aksoy, S. Yaman, Z. Arik, F.T. Kos, M.B. Akinci, B. Civelek, N.Y. Ozdemir, D. Uncu, N. Zengin, “Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity”, J BUON, 18, 274-280, 2013
A107. Tonyali, O., M. Benekli, V. Berk, U. Coskun, M. Ozkan, R. Yildiz, E. Ucgul, A. Sevinc, D. Uncu, U. Demirci, S. Buyukberber, Anatolian Society of Medical Oncology (ASMO), “Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer”, J Cancer Res Clin Oncol, 139, 981-986, 2013
A108. Uncu, D., S. Aksoy, B. Çetin, T. Yetişyiğit, N. Özdemir, V. Berk, F. Dane, A. Inal, H. Harputluoğlu, B. Budakoğlu, D. Koca, A. Sevinç, S. Cihan, A.G. Durnalı, M. Özkan, M.A. Öztürk, A. Işıkdoğan, S. Büyükberber, M. Benekli, T. Köş, N. Alkış, H. Karaca, N.S. Turhal, N. Zengin, “Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients”, Oncology, 84, 240-245, 2013
A109. Arpaci, E., T. Yetisyigit, M. Seker, D. Uncu, U. Uyeturk, B. Oksuzoglu, U. Demirci, U. Coskun, M. Kucukoner, A. Isıkdogan, M. Inanc, N. Alkis, M. Ozkan, “Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology”, Med Oncol, 30, 469, 2013
A110. Kaplan, M.A., A. Isikdogan, M. Gumus, U.Y. Arslan, C. Geredeli, N. Ozdemir, D. Koca, F. Dane, A. Suner, E.F. Elkiran, M. Kucukoner, M. Seker, K. Helvaci, T. Guler, D. Uncu, A. Inal, R. Yildiz R, “Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology”, J Pediatr Hematol Oncol, 35, 83-89, 2013
A111. Sendur, M.A., N.Y. Ozdemir, M.B. Akinci, D. Uncu, N. Zengin, S. Aksoy, “Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?”, World J Gastroenterol, 19, 144-146, 2013
A112. Seker, M., A. Sevinc, R. Yildiz, S. Cihan, M.A. Kaplan, A. Gokdurnali, F. Dane, E. Yaman, H. Karaca, D. Colak, U. Uyeturk, A. Bilici, N.Y. Ozdemir, M.E. Kalender, D. Uncu, T. Salepci, A. Isikdogan, M. Benekli, M. Ozkan, M. Gumus, U. Coskun, C. Camci, B. Oksuzoglu, S. Buyukberber, Anatolian Society of Medical Oncology (ASMO), “Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey”, Hepatogastroenterology, 60, 768-775, 2013
A113. Kucukoner, M., E. Arpaci, A. Isikdogan, M. Bilici, D. Uncu, B. Cetin, F. Dane, M. Inanc, A.S. Ekinci, A. Inal, K. Cayir, T. Yetisyigit, N. Ozdemir, M.A. Kaplan, S. Aksoy, N. Alkıs, S.B. Tekin, C. Eroglu, S. Turhal, S. Buyukberber,“Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy”, Neoplasma, 60, 19-25, 2013
A114. Cetin, B., M. Benekli, B. Oksuzoglu, L. Koral, A. Ulas, F. Dane, I. Turker, M.A. Kaplan, D. Koca, C. Boruban, B. Yilmaz, A. Sevinc, V. Berk, A. Isıkdogan, D. Uncu, H. Harputluoglu, U. Coskun, S. Buyukberber,“Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience”, Onkologie, 35, 740-745, 2012
A115. Baykara, M., S.C. Ozturk, S. Buyukberber, K. Helvaci, N. Ozdemir, N. Alkis, V. Berk, D. Koca, U. Coskun, B. Oksuzoglu, D. Uncu, E. Arpaci, B.O. Ustaalioglu, U. Demirci, M. Kucukoner, G.G. Dogu, S. Alici, T. Akman, M. Ozkan, U.Y. Aslan, A.G. Durnali, M. Benekli, “Clinicopathological features in bilateral breast cancer”, Asian Pac J Cancer Prev, 13, 4571-4575, 2012
A116. Altinbas, M., M.E. Kalender, B. Oven, A. Sevinc, H. Karaca, M.A. Kaplan, S. Alici, E. Arpaci, R. Yildiz, D. Uncu, C. Camci, M. Gumus,“Weekly topotecan for recurrent small cell lung cancer - a retrospective Anatolian Medical Oncology Group study”, Asian Pac J Cancer Prev, 13, 2909-2912, 2012
A117. Kucukoner, M., A. Isikdogan, E. Arpaci, M. Bilici, D. Uncu, B. Cetin, F. Dane, M. Inanc, M.A. Kaplan, K. Cayir, T. Yetisyigit, N. Ozdemir, A. Inal, S. Aksoy, N. Alkis, S.B. Tekin, C. Eroglu, S. Turhal, M. Benekli, S. Buyukberber, “Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology”, Hepatogastroenterology, 59, 2343-2347, 2012
A118. Inal, A., F.T. Kos, A. Algin, R. Yildiz, M. Dikiltas, I.T. Unek, D. Colak, E.T. Elkiran, K. Helvaci, C. Geredeli, F. Dane, O. Balakan, M.A. Kaplan, A.G. Durnali, H. Harputoglu, G. Goksel, N. Ozdemir, S. Buyukberber, M. Gumus, M. Kucukoner, M. Ozkan, D. Uncu, M. Benekli, A. Isikdogan,“Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study”, Neoplasma, 59, 297-301, 2012
A119. Kos F.T., B. Civelek, M.M. Seker, Z. Arik, S. Aksoy, D. Uncu, N. Ozdemir, N. Zengin, “Is there an association between blood group and survival in pancreatic cancer?” , Asian Pac J Cancer Prev, 13, 6151-6153, 2012
A120. Civelek B., S. Aksoy, T. Kös, M.M. Seker, Z. Arik, M.A. Sendur, S. Yaman, S. Cihan, N.Y. Ozdemir, D. Uncu, S. Kulaçoglu, N. Zengin, “Isolated Testicular Metastasis of Gastric Cancer”, J Gastrointest Cancer, 43 (suppl 1), S64-S66, 2011
A121. Cihan, S., D. Uncu, N.A. Babacan, N. Ozdemir, H. Odabas, S. Aksoy, B. Oksuzoglu, N. Zengin, “Adjuvant Modified FOLFOX-4 in Patients with Stage III Rectum Adenocarcinoma”, Asian Pac J Cancer Prev, 12, 967-970, 2011
A122. Arslan, U.Y., B. Oksüzoğlu, N. Ozdemir, S. Aksoy, N. Alkış, A. Gök, M.A. Kaplan, M. Gümüs, V. Berk, D. Uncu, M. Baykara, D. Çolak, U. Uyetürk, I. Türker, A. Işıkdoğan, “Outcome of non-metastatic male breast cancer: 118 patients”, Med Oncol, doi: 10.1007/s12032-011-9978-9, 2011
A123. Isik, M., S. Caner, M.M. Seker, B. Civelek, H. Odabas, N. Ozdemir, D. Uncu, N. Zengin, “Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated”, Journal of BUON, 16, 253-256, 2011
A124. Odabas, H., N. Ozdemir, M. Isik, H. Abali, B. Oksuzoglu, T. Kos, B. Civelek, N.A. Babacan, D. Uncu, N. Zengin, “Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment”, Journal of BUON, 16, 460-463, 2011
A125. Odabas, H., N. Ozdemir, H. Abali, B. Oksuzoglu, M. Isik, D. Uncu, S. Cihan, M. Seker, N. Zengin, “First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab”, Journal of BUON, 16, 247-252, 2011
A126. Kos, F.T., S. Aksoy, H. Odabas, N. Ozdemir, B. Oksuzoglu, D. Uncu, N. Zengin, “Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study”, Journal of BUON, 16, 464-468, 2011
A127. Sendur, M.A.N., S. Aksoy, Z. Arık, Ş. Yaman, N.Y. Ozdemir, D. Uncu, N. Zengin, “Bevacizumab: a New Potential Therapeutic Option in Sinusoidal Obstruction Syndrome”, Asian Pac J Cancer Prev, 12, 1-2, 2011
A128. Ozdemir, N., S. Aksoy, T. Eren, D. Uncu, M.B. Akıncı, M.E. Alagüney, N. Zengin, “Successful management of bevacizumab-associated surgical bleeding with an Ankaferd blood stopper”, Asian Pac J Cancer Prev, 12, 1103-1104, 2011
A129. Kos, F.T., D. Uncu, B. Oksuzoglu, S. Aksoy, N. Ozdemir, H. Odabas, M. Isik, B. Civelek, N. Zengin, “Long term survival in a metastatic alveolar soft part sarcoma at the time of diagnosis: a case with 17 years of follow-up”, Journal of BUON, 16, 376-377, 2011
A130. Sendur, M.A., S. Aksoy, Z. Arık, S. Yaman, N.Y. Ozdemir, D. Uncu, N. Zengin, “Small Cell carcinoma of the urinary bladder with hypercalcemia”, Med Oncol, doi: 10.1007/s12032-011-9947-3, 2011
A131. Kos, F.T., D. Uncu, N. Ozdemir, B. Budakoglu, H. Odabas,H. Abali, B. Oksuzoglu, S. Aksoy, N. Zengin, “Comparison of CFF (Cisplatin- 5-Fluorouracil- Folinic Acid) versus Modified DCF (Docetaxel- Cisplatin- 5-Fluorouracil) Regimens in the First Line Treatment of Metastatic Gastric Cancer”, Chemotherapy, doi: 10.1159/000327840, 2011
A132. Alkis, N., U. Demirci, M. Benekli, U. Yılmaz, A. Isikdogan, A. Sevinc, N.Y. Ozdemir, D. Koca, T. Yetisyigit, M.A. Kaplan, D. Uncu, T. Unek, M. Gumus, “Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure”, Journal of BUON, 16, 80-83, 2011
A133. Seker, M.M., S. Aksoy, N.Y. Ozdemir, D. Uncu, B. Civelek, M.B. Akıncı, N. Zengin, “Succesful treatment of chronic hiccup with baclofen in cancer”, Med Oncol, doi: 10.1007/s12032-011-9910-3, 2011
A134. Özet, A., D. Uncu, O. Kuzhan, Ş. Kömürcü, M. Öztürk, F. Arpacı, B. Öztürk, “Capecitabine and oral cyclophosphamide in metastatic breast cancer patients with anthracyclin and taxan resistance”, International Journal of Hematology and Oncology, doi: 10.4999/uhod.08079, 2011
A135. Uncu, D., N.Y. Ozdemir, S. Aksoy, H. Abali, B.C. Oksuzoglu, B. Budakoglu, R. Yildiz, N. Aslan, N. Zengin, “Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma”, Asian Pac J Cancer Prev, 11, 1493-1497, 2010
A136. Yaman, E., S. Buyukberber, M. Benekli, Y. Oner, U. Coşkun, M. Akmansu, B. Ozturk, A.O. Kaya, D. Uncu, R. Yildiz, “Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide”, Clin Neurol Neurosurg, 112, 662-667, 2010
A137. Uncu, D., F. Arpaci, M. Beyzadeoglu, A. Gunal, S. Surenkok, M. Ozturk, A. Ozet, “Meningeal carcinomatosis: An extremely rare involvement of urinary bladder carcinoma”, Tumori, 96, 352-354, 2010
A138. Isik, M., M.M. Seker, H. Odabas, F.T. Kos, D. Uncu, N. Zengin, “Gemcitabine and cisplatin in patients with carcinoma of unknown primary site”, Med Oncol, doi: 10.1007/s12032-010-9465-8, 2010
A139. Ozdemir, NY., H. Abali, B. Oksuzoglu, B. Budakoglu, D. Uncu, T. Guler, H. Odabasi, N Zengin, “The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma”, Med Oncol, 27, 680-684, 2010
A140. Yildiz, R., M.E. Kalender, F. Dane, A. Sevinc, M. Gumus, C. Camci, S. Alici, A.O. Kaya, E. Yaman, B. Ozturk, U. Coskun, M. Benekli, D. Uncu, S. Buyukberber, “Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens”, J Oncol Pharm Pract, 16, 173-178, 2010
A141. Coskun, U., A.O. Kaya, N. Alkis, S. Buyukberber, S. Alici, G. Celenkoglu, D. Uncu, M. Ozkan, A. Sevinc, M. Benekli, “UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes”, Onkologie, 32, 562-566, 2009
A142. Ozet, A., D. Uncu, O. Kuzhan, M. Ozturk, A. Gunal, F. Kilicli, F. Arpaci, “Metastatic breast cancer. Occurance after autologous hematopoietic stem cell transplantation for multipl myeloma: case report”, Türkiye Klinikleri J Med Sci, 28, 758-761, 2008
A143. Pamukcuoglu, M., B. Oksuzoglu, H. Abali, M. Akoglu, F. Atalay, B. Budakoglu, D. Uncu, N. Ozdemir, T. Guler, N. Zengin, “Prognostic factors and clinicopathological characteristics of carcinoma of ampulla Vateri”,International Surgery, 93, 214-219, 2008
A144. Yaman, E., S. Buyukberber, A. Uner, U. Coskun, M. Akmansu, D. Uncu, N. Zengin, M. Benekli, D. Yamac, B. Ozturk, A.O. Kaya, R. Yildiz, S. Ozkan, N. Gunel, “Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation Treatment”, Onkologie, 31, 309-313, (2008). Erratum: Onkologie, 31, 403, 2008
A145. Budakoglu, B., H. Abali, D. Uncu, N. Yildirim, B. Oksuzoglu, N. Zengin, “Good tolerance of weekly irinotecan in a patient with metastatic colorectal cancer on chronic hemodialysis”, J Chemotherapy, 17, 452-453, 2005
A146. Yildirim, N., B.Oksuzoglu, B. Budakoglu, M. Vural, H. Abali, D. Uncu, N. Zengin, “Primary duodenal diffuse large cell non-hodgkin lymphoma with involvement of ampulla vateri: report of 3 cases”, Hematology, 10, 371-374, 2005
B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler:
B1. Aktürk Esen Selin, Uncu Doğan (2022). Kolon Kanserinde Tümör Lokalizasyonunun Tümörün Patolojik Özelliklerine Ve Sağ Kalıma Etkisi . 2. Uluslararası Tıp Ve Sağlık Bilimlerinde Yenilikçi Yaklaşımlar Kongresi , 212-212
B2. Aktürk Esen Selin, Uncu Doğan (2022). Pankreas Kanseri Hastalarında Kan Gruplarının Genel Sağ Kalım Üzerine Etkisi. 5. Uluslararası Tıp Bilimleri Ve Multidisipliner Yaklaşımlar Kongresi , 548-549
B3. Aktürk Esen Selin, Büyükaksoy Müge, Uncu Doğan (2022). Akciğer Nöroendokrin Neoplazilerinin Klinikopatolojik Özellikleri: Tek Merkez Deneyimi. 5. Muğla Multidisipliner Onkolojik Araştırmalar Kongresi , 41-42
B4. Büyükaksoy Müge, Aktürk Esen Selin, Uncu Doğan (2022). Clinical and Overall Survival Characteristics of Non-metastatic Skin and Uveal Malignant Melanoma Patients. 2nt İnternational Dr.Safiye Ali Congress On Multıdıcıplınary Studıes In Health Scıences , 62-63
B5. Ergün Yakup, Uçar Gökhan, Açıkgöz Yusuf, Dirikoç Merve, Aktürk Esen Selin, Bardakçı Murat, Karaçin Cengiz, Uncu Doğan (2022). Efficacy ofpostoperative radiotherapy (PORT) in stage IIIA N2 non-small cell lung cancer:Meta-analysis of randomized controlled studies. ESMO Congress 2022
B6. Aktürk Esen Selin, Uçar Gökhan, Uncu Doğan (2022). Nadir Görülen Epiteloid Hemanjioendotelyomalı 4 Vaka Sunumu. 2.Uluslararası Tıp Bilimleri Ve Multidisipliner Yaklaşımlar Kongresi , 521-522
B7. Aktürk Esen Selin, Uncu Doğan (2022). Erkek Meme Kanseri Hastalarının Klinik Ve Patolojik Özellikleri. 5 th INTERNATIONAL HEALTH SCIENCE and LIFE CONGRESS (IHSLC 2022) , 49-49
B8. Ergün Yakup, Uçar Gökhan, Açıkgöz Yusuf, Dirikoç Merve, Aktürk Esen Selin, Bardakçı Murat, Uncu Doğan (2021). Efficacy and safety of Anti-EGFR TKIs combined with bevacizumab or ramucirumab in the first-line treatment of non-small cell lung cancer: Meta-analysis of randomized controlled trials. ESMO Congress 2021
B9. Gürler Fatih, Aktürk Esen Selin, Kurt İnci Bediz, Sütcüoğlu Osman, Uçar Gökhan, Uncu Doğan, Turhan Nesrin, Akyürek Nalan, Özdemir Nuriye, Özet Ahmet, Yazıcı Ozan (2021). RetrospectiveanalysisofPDL-1,LAG3,TIM3,OX40LandMSI tatusin gastroenteropancreatic neuroendocrinetumors (GEPNETs). ESMO Congress 2021
B10. Sılay K, Ergün Y,Arık G, Doğrul RT, Öksüzoğlu B, Uncu D, Özdemir NY. Potentially inappropriate medications and tyrosine kinase inhibitors–drug interactions in geriatric patients. Akademik GeriatriDerneği e-Kongre 2020: Covid-19 veGeriatrideGüncelleme; 17–18 Ekim 2020; Türkiye. Bildiri Kitabı, SS-097.
B11. Ulas Isik, Osman Kostek, Gokcen Demiray, Ahmet Dirican, Melih Simsek, Mahmut Büyüksimsek, Gokhan Ucar, Ulug Mutlu Gunaydin, Teoman Sakalar, Altay Aliyev, Atakan Demir, Serdar Turhal, Kezban Nur Pilanci, Umut Kefeli, Ali Gokyer, Semra Paydas, Dogan Uncu, Ilker Nihat Okten, Kazim Uygun, Devrim Cabuk, Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer, J Clin Oncol 37, (suppl; abstr e16075) 2019
B12. Ucar G, Eren T, Ergun Y,Yazici O, Uncu D, Ozdemir M, Bostanci EB, Ozdemir N. Theimportance of primarytumorlocalization in locally advanced gastric cancer with neoadjuvant chemotherapy. Presented at: 8th International GastrointestinalCancer Conference; 2018.
B13. Eren, T., O. Yazıcı, N.Y. Özdemir, D. Uncu, Ö. Bal, N. Zengin, “A complete radıologıc response wıth folfox plus panitumumab in young liver metastatic rectum cancer”, 7TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 15-17, 2017
B14. Eren, T., N.Y. Özdemir, Y. Ergün, G. Uçar, O. Yazıcı, D. Uncu, N. Zengin, “Leptomenıngeal metastasıs: an unusualn metastasis of rectum cancer”, 7TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 15-17, 2017
B15. Eren, T., O. Yazıcı, N.Y. Özdemir, G. Uçar, Y. Ergün, D. Uncu, N. Zengin, “A rare hormone posıtıve tumor detected ın pregnancy: aggresıve angıomyxoma”, 7TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 15-17, 2017
B16. Eren, T., N.Y. Özdemir, O. Yazıcı, Y. Ergün, G. Uçar, D. Uncu, Ö. Bal, N. Zengin, “A very rare tumor of gallbladder: schwannoma”, 7TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 15-17, 2017
B17. Kilickap, S., M. Gumus, D. Uncu, M. Ozkan, I. Çiçin, et al. “Outcomes of Turkish National Breast Cancer Registry”, J Clin Oncol, 35, (suppl; abstr e12517), ASCO Annual meeting, Chicago, June 2017
B18. Cicin, I., M. Gumus, D. Uncu, M. Ozkan, S. Klılıçkap, T. Elkıran, et al, “Characteristics of Turkish colorectal cancer patients and bevacizumab preference”, J Clin Oncol, 35, (suppl; abstr e15055), ASCO Annual meeting, Chicago, June 2017
B19. Bozkaya, Y., N. Özdemir, O. Yazıcı, G.U. Erdem, N.S. Demirci, M. Doğan, D. Uncu, N. Zengin, “Clınıcal factors predıctıng pathologıc complete response ın locally advanced rectal cancer”, 6TH International Gastrointestinal Cancer Conference, Antalya, Turkey, December 2-4, 2016
B20. Bozkaya, Y., N.Y. Özdemir, A. Çolak, O. Yazıcı, D. Uncu, M. Doğan, N. Zengin, “Gastrıc adenocarcınoma wıth neuroendocrıne dıfferentıatıon: clınıcopathologıcal features and modıfıed dcf therapy”, 6TH International Gastrointestinal Cancer Conference, Antalya, Turkey, December 2-4, 2016
B21. Yazıcı, O., D. Yazılıtaş, N. Özdemir, S. Demirci, G. Erdem, Y. Bozkaya, C. Hocazade, G. Uçar, Ö. Bal, M. Doğan, D. Uncu, M.A Şendur, N. Zengin, “The effect of body mass index in patients with relapsed colorectal cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B22. Hocazade, C., N. Yıldırım, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, M. Doğan, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, C. Daloğlu, N. Zengin, “Is tumor size a predictive marker of survival in patients with colorectal cancer after curative surgery”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B23. Hocazade, C.,D. Uncu, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.U. Erdem, N.S. Demirci, G. Uçar, N. Yıldırım, M. Doğan, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Intra abdominal sarcomas”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B24. Bozkaya, Y. G.U. Erdem, N. Yıldırım, C. Hocazade, O. Yazıcı, N. Demirci, Ş. Toptaş, G. Uçar, D. Uncu, N. Zengin, “Evaluation of symptomatic venous thromboembolism in patients with gastric cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B25. Bozkaya, Y. G.U. Erdem, N. Yıldırım, O. Yazıcı, C. Hocazade, N. Demirci, D. Uncu, Ş. Toptaş, M. Dogan, D. Yazılıtaş, G. Uçar, N. Zengin, “Evaluation of port-related thrombosis in patients with colon and gastric cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B26. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, N. Yıldırım, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Effect of addıtıonal oxalıpaltın to ınfusıonal FUFA treatment ın patıent wıth stage II rectum cancer”, oral presentation, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B27. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, N. Yıldırım, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Comparison of prediagnostic hematological parameters between colorectal cancer patients and healthy individuals”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B28. Bozkaya, Y. G.U. Erdem, C. Hocazade, O. Yazıcı, N. Demirci, N. Yıldırım, G. Uçar, D. Uncu, M. Dogan, Ş. Toptaş, D. Yazılıtaş, N. Zengin, “Gastric papillary adenocarcinoma: a case report”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B29. Bozkaya, Y. G.U. Erdem, C. Hocazade, N. Demirci, O. Yazıcı, N. Yıldırım, D. Uncu, Ş. Toptaş, G. Uçar, D. Yazılıtaş, Ö. Bal, M. Dogan, N. Zengin, “Solid pseudopapillary neoplasm of the pancreas in a young woman”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B30. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, N. Yıldırım, D. Uncu, D. Yazılıtaş, G. Uçar, E. Algın, Ö. Bal, N. Zengin, “The Effect of Lymphovascular Invasion Status on Survival in Patients with Non-Metastatic Colon Cancer”, oral presentation, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B31. Hocazade, C.,N. Yıldırım, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.U. Erdem, N.S. Demirci, G. Uçar, M. Doğan, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Predictive Factors of Liver Metastasis After Curative Treatment for Colorectal Cancer”,oral presentation, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B32. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, G. Uçar, N. Yıldırım, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Clinical Significance of White Blood Cell-Lymphocyte Ratio in Colorectal Cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B33. Bozkaya, Y., N.S. Demirci, G.U. Erdem, C. Hocazade, O. Yazıcı, N. Özdemir, D. Uncu, M. Doğan, D. Yazılıtaş, Ş. Toptaş, G. Uçar, N. Zengin, “Gastric medullary carcinoma: a case study”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B34. Bozkaya, Y., O. Yazıcı, C. Hocazade, N.S. Demirci, G.U. Erdem, D. Yazılıtaş, D. Uncu, N. Özdemir, M. Doğan, G. Uçar, N. Zengin, “Esophagus carcinoma: a case report”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B35. Bozkaya, Y., N.S. Demirci, G.U. Erdem, O. Yazıcı, C. Hocazade, D. Uncu, N. Yıldırım, M. Doğan, G. Uçar, Ş. Toptaş, D. Yazılıtaş, N. Zengin, “Undifferantiated osteoclast like giant cell carcinoma of pancreas: a case study”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B36. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, G. Uçar, N. Yıldırım, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Is there any assocıatıon between thyroid hormones and survival ın patents wıth colorectal cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B37. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, G. Uçar, N. Yıldırım, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin, “Clinical Significance of Platelet-Lymphocyte Ratio and Platelet Count in Colorectal Cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B38. Hocazade,C., M. Doğan, Y. Bozkaya, O. Yazıcı, Ş. Toptaş, G.Umut Erdem, N.S. Demirci, G. Uçar, N. Yıldırım, D. Uncu, D. Yazılıtaş, E. Algın, Ö. Bal, N. Zengin,“Lipids and colorectal cancer”, 5TH International Gastrointestinal Cancer Conference, İstanbul, Turkey, December 4-6, 2015
B39. Coskun, U., K. Altundag, M. Aliustaoglu, D. Uncu, M. Ozkan, I. Cicin, A. Ciltas, T. Elkiran, M. Kocer, A. Isikdogan, A. Karaoglu, S.B. Tekin, N. Avci, A. Ulas, B. Oksuzoglu, F. Ozdemir, E. Dumanli, A. Sevinc, S. Kilickap, M. Benekli, R. Uslu, O. Ozyilkan, B. Yalcin, M.C. Boruban, F. Dane, O. Kara, G.G. Dogu, B. Ozturk, A.O. Kaya, M. Gumus, H. Turna, “Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry”, J Clin Oncol, 33, (suppl; abstr e12657), ASCO Annual Meeting, Chicago, USA, 2015
B40. Benekli, M., K. Altundag, E. Dumanli, A. Isikdogan, A. Karaoglu, S.B. Tekin, B. Oksuzoglu, M. Kocer, A. Sevinc, M. Cem Boruban, H. Turna, R. Uslu, O. Ozyilkan, B. Yalcin, U. Coskun, S. Kilickap, G.G. Dogu, B. Ozturk, M. Gumus, S. Buyukberber, D. Uncu, O. Kara, M. Aliustaoglu, M. Ozkan, I. Cicin, E.T. Elkiran, F. Dane, N. Avci, A. Ulas, F. Ozdemir, A.O. Kaya, “Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry”, J Clin Oncol, 33, (suppl; abstr e12653), ASCO Annual Meeting, Chicago, USA, 2015
B41. Kilickap, S., K. Altundag, E. Dumanli, M. Gumus, R. Uslu, O. Ozyilkan, B. Yalcin, O. Kara, G.G. Dogu, B. Ozturk, A.O. Kaya, M. Aliustaoglu, D. Uncu, F. Ozdemir, I. Cicin, M. Ozkan, M. Kocer, H. Turna, S. Buyukberber, M. Benekli, U. Coskun, A. Karaoglu, S. Basol Tekin, F. Dane, N. Avci, A. Ulas, B. Oksuzoglu, A. Sevinc, M.C. Boruban,“Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry”, J Clin Oncol, 33, (suppl; abstr e12656), ASCO Annual Meeting, Chicago, USA, 2015
B42. Buyukberber, S., E. Dumanli, D. Uncu, M. Ozkan, R. Uslu, G.G. Dogu, O. Kara, H. Abali, H. Turna, B. Ozturk, A. Sevinc, M. Uysal, B. Yalcin, F. Dane, M. Aliustaoglu, I. Cicin, S.B. Tekin, M. Gumus, S. Kilickap, M. Benekli, M. Kocer, B. Oksuzoglu, A. Isikdogan, F. Ozdemir, E.T. Elkiran, A. Karaoglu, C. Boruban, N. Avci, “Turkish National Gastric Cancer Registry”, J Clin Oncol, 33, (suppl; abstr e12645), ASCO Annual Meeting, Chicago, USA, 2015
B43. Benekli, M., E. Dumanli, S. Kilickap, D. Uncu, M. Aliustaoglu, I. Cicin, M. Gumus, M. Ozkan, M. Kocer, A. Karaoglu, F. Dane, A. Isikdogan, T. Elkiran, B. Yalcin, M. Uysal, B. Oksuzoglu, M.C. Boruban, A. Ulas, H. Abali, S. Buyukberber, S. Basol Tekin, N. Avci, A. Sevinc, F. Ozdemir, R. Uslu, H. Turna, B. Ozturk, O. Kara, A.O. Kaya,“Turkish National Colon Cancer Registry”, J Clin Oncol, 33, (suppl; abstr e12646), ASCO Annual Meeting, Chicago, USA, 2015
B44. Kaplan, M.A, Z. Urakci, D. Uncu, F. Dane, M. Ozkan, T. Akman, H. Harputluoglu, B. Oksuzoglu, M. Kucukoner, N. Ozdemir, İ.V. Bayoglu, Y. Gunaydin, M. Baykara, D. Yazilitas, E. Cubukcu, A. Suner, M. Bilici, A. Isikdogan, “Breast cancer subtypes and the risk of distant relapse after breast conserving surgery or mastectomy: An Anatolian Society of Medical Oncology study”, J Clin Oncol, 33, (suppl; abstr e12052), ASCO Annual Meeting, Chicago, USA, 2015
B45. Ciltas, A., M. Karaca, D. Uncu, M. Ozkan, M. Aliustaoglu, S.B. Tekin, I. Cicin, M. Kocer, F. Dane, B. Oksuzoglu, A. Isikdogan, F. Ozdemir, E.T. Elkiran, A. Karaoglu, B. Yalcin, A. Sevinc, M. Uysal, C. Boruban, M. Benekli, S. Buyukberber, N. Avci, B. Ozturk, A. Ulas, H. Turna, R. Uslu, E. Dumanli, H. Abali, O. Kara, M. Gumus,“Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry”, J Clin Oncol, 33, (suppl; abstr e15056), ASCO Annual Meeting, Chicago, USA, 2015
B46. Dogan, M., E. Algin, Z.T. Guven, M. Baykara, T.F. Kos, D. Uncu, O. Bal, N. Zengin, “The prognostic significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and prognostic nutritional index in metastatic pancreas cancer”, abstr 2292, ESMO 2014 Congress, Vienna, Austria, Sep 25-29, 2015
B47. Kaplan, M.A., H. Odabasi, N. Ozdemir, H. Harputluoglu, M. Aliustaoglu, V. Berk, Y. Gunaydin, D. Uncu, T. Elkiran, D. Aydin, A. Isikdogan, “Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node-positive breast cancer patients?”,San Antonio Breast Cancer Symposium, p3-01-21, San Antonio, Texas, USA, Dec 8-12, 2015 B48. Sevinc, A., M. Ozkan, A. Ozet, F. Dane, B. Oksuzoglu, A. Isikdogan, F. Ozdemir,
B48. Kaplan, M.A., H. Odabasi, N. Ozdemir, H. Harputluoglu, M. Aliustaoglu, V. Berk, Y. Gunaydin, D. Uncu, T. Elkiran, D. Aydin, A. Isikdogan, “Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node-positive breast cancer patients?”,San Antonio Breast Cancer Symposium, p3-01-21, San Antonio, Texas, USA, Dec 8-12, 2015
B49. Sevinc, A., M. Ozkan, A. Ozet, F. Dane, B. Oksuzoglu, A. Isikdogan, F. Ozdemir, D. Uncu, M. Gumus, T. Evrensel, A. Yaren, O. Kara, S.B. Tekİn, “Comparıson of the effıcacy of fılgrastım (neupogen®) and bıosımılar fılgrastım (leucostım®) ın patıents wıth chemotherapy-ınduced neutropenıa: a natıonwıde observatıonal study”, Annals of Oncology, abstr p1501, ESMO 2014 Congress, Madrid, Spain, 2014
B50. Sendur, M.A., S. Aksoy, D. Uncu, H. Demir, S. Yuksel, A.S. Ekinci, M.A. Kaplan, B.B. Ustaalioglu, G. Tufan, M. İnanc, N. Ozdemir, M. Artac, D. Taştekin,T. Kacan, A. Oguz, E. Arpaci, D. Yazılıtas, M. Gumus, N. Zengin, M.K. Altundag, “Effıcacy of adjuvant 9-weeks trastuzumab ın node-negatıve t1a/b her2-posıtıve breast CANCER”, Annals of Oncology, abstr p298, ESMO 2014 Congress, Madrid, Spain, 2014
B51. Uncu, D., I.V. Bayoglu, U.Y. Arslan, M. Kucukoner, M. Artac, D. Koca, A. Oguz, U. Demirci, E. Arpaci, M. Dogan, Y. Kucukzeybek, I. Turker, A. Isikdogan, T. Guler, N. Zengin, “Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients”,J Clin Oncol, 32, (suppl; abstr e11586), ASCO Annual Meeting, Chicago, USA, 2014
B52. Coskun, U., M. Gumus, D. Uncu, M. Ozkan, I. Cicin, K. Altundag, T. Elkiran, M. Kocer, A. Karaoglu, N. Avci, F. Ozdemir, E. Cubukcu, M.C. Boruban, A. Sevinc, B. Oksuzoglu, H. Turna, B. Yalcin, E. Dumanli, F. Ozdener, M. Benekli, “Turkish Breast Cancer Registry: A multicenter epidemiologic study”,J Clin Oncol, 32, (suppl; abstr e12518), ASCO Annual Meeting, Chicago, USA, 2014
B53. Sevinc, A., M. Seker, R. Yildiz, S. Cihan, M.A. Kaplan, F. Dane, H. Karaca, U. Uyeturk, A. Bilici, N. Ozdemir, D. Uncu, T. Salepci, A. Isikdogan, M. Benekli, M. Ozkan, M. Gumus, B. Oksuzoglu, “The clinical and pathologic characteristics of 400 gastrointestinal stromal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery”, J Clin Oncol, 32, (suppl; abstr e15176), ASCO Annual Meeting, Chicago, USA, 2014
B54. Yazıcı, O., S. Aksoy, O. Uçar, N. Ozdemir, M. Demir, M.A. Sendur, Z. Arik, S. Yaman, T. Eren, D. Uncu, N. Zengin, “Arrhytmias during and after zoledronic acid infusion in patients with bone metastasis”, J Clin Oncol, 31, (suppl; abstr e20614), ASCO Annual Meeting, Chicago, USA, 2013
B55. Yildiz, R., S. Buyukberber, D. Koca, L. Koral, A. Ciltas, O. Umit Unal, M. Gumus, N. Ozdemir, F. Dane, V. Berk, M.A. Kaplan, T. Elkiran, M.C. Boruban, U. Coskun, D. Aydin, D. Uncu, M. Ozkan, A. Isikdogan, M. Benekli, “The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience”, J Clin Oncol, 31, (suppl; abstr e14705), ASCO Annual Meeting, Chicago, USA, 2013
B56. Yasar, N., O.U. Unal, C. Geredeli, A. Inal, V. Berk, E. Sari, A. Durnali, A. Suner, N. Ozdemir, B. Budakoglu, U. Demirci, O. Gumussoy, D. Uncu, C.M. Boruban, I. Oztop, M. Ozkan, M. Gumus, T. Elkiran, “Efficacy and safety results of pemetrexed administration in non-small cell lung cancers, a multicenter study of the Association of Anatolian Medical Oncology”, J Clin Oncol, 31, (suppl; abstr e19107), ASCO Annual Meeting, Chicago, USA, 2013
B57. Sendur, M., S. Aksoy, O. Yazıcı, S. Yaman, F.T. Kos, N.Y. Ozdemir, D. Uncu D, M. Dogan, N. Zengin, “Evaluation of vitamin D status and risk factors and osteopenia/osteoporosis in colorectal cancer survivors”, 17th ECCO-38th ESMO-32nd ESTRO, Amsterdam, 27 September-01 October, 2013
B58. Sendur, M., S. Aksoy, S. Yaman, O. Yazıcı, N.Y. Ozdemir, D. Uncu, N. Zengin, “Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancer”, 17th ECCO-38th ESMO-32nd ESTRO, Amsterdam, 27 September-01 October, 2013
B59. Dogan, M., M.A. Şendur, O. Yazıcı, N.Y. Özdemir, Ş. Yaman, D. Uncu, D. Yazılıtaş, N. Zengin, “Characteristics of HbsAg seroposıtive non-hepatocellular carcinoma cancer patients”, 3RD İnternational Gastrointestinal Cancer Conference, Antalya, Turkey, December 13-15, 2013
B60. Doğan, M., G.U. Erdem, A.B. İleri, D. Uncu, N. Y. Özdemir, D. Yazılıtaş, S. Kulaçoğlu, N. Zengin, “A rare metastatic pattern in renal cell carcinoma: colon metastasis”, 3RD İnternational Gastrointestinal Cancer Conference, Antalya, Turkey, December 13-15, 2013
B61. Doğan, M., D. Uncu, S. Cihan, N. Y. Özdemir, D. Yazılıtaş, S. Aksoy, N. Zengin, “Long term outcomes of adjuvant chemotherapy including oxaliplatin with sequential chemoradiotherapy in operated rectal carcinoma”, 3RD İnternational Gastrointestinal Cancer Conference, Antalya, Turkey, December 13-15, 2013
B62. Doğan, M., D.T. Ünal, M. Vural, G.U. Erdem, D. Uncu, N. Zengin, “Gholangiocellular carcinoma: parotideal metastasis and hepatocolonic fistulisation”, 3RD İnternational Gastrointestinal Cancer Conference, Antalya, Turkey, December 13-15, 2013
B63. Kucukoner, M., E. Arpaci, A. Isikdogan, M. Bilici, D. Uncu, B. Cetin, F. Dane, K. Cayir, M. Inanc, A.Ş. Ekinci, A. Inal, T. Yetisyigit, N. Ozdemir, M.A. Kaplan, S. Aksoy, N. Alkis, S.B. Tekin, C. Eroglu, S. Turhal, S. Buyukberber, “Prognostic analysis of the patients with operable gastric cancer and the importance of tolerability of therapy: Study of Anatolian Society of Medical Oncology”, J Clin Oncol, 30, (suppl; abstr e14526), ASCO Annual Meeting, Chicago, USA, 2012
B64. Şendur, M.A., S. Aksoy, S. Yaman, F.T. Kös, Z. Arık, B. Civelek, N. Özdemir, D. Uncu, N. Zengin, “Administration of contrast media just before the cisplatin-based chemotherapy increases the cisplatin-induced nephrotoxicity”,J Clin Oncol, 30, (suppl; abstr e13031), ASCO Annual Meeting, Chicago, USA, 2012
B65. Çiltaş, A., S. Büyükberber, R. Yıldız, E. Arpacı, B. Budakoğlu, M. Küçüköner, M.A. Şendur, O. Balaban, U. Kefeli, V. Berk, H. Harputluoğlu, B. Öksüzoğlu, D. Uncu, N. Alkış, A.O. Kaya, M. Gümüş, M. Benekli, U. Coşkun, “Efficacy and Toxicity Evaluation of Cisplatin+ Capacitabine Chemotherapy in locally advanced and metastatic gastric cancer patients”,1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B66. Civelek, B., S. Sezer, T. Kös, M. Şeker, O. Yazıcı, S. Yaman, M.A. Şendur, N. Yıldırım, D. Uncu, N. Zengin, “N-Terminal PRO-BNP measurement for cardiac damage during cardiotoxic chemotherapy”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B67. Eren, T., N. Özdemir, O. Yazıcı, F.T. Köş, B. Civelek, Ş. Yaman, M.A. Şendur, D. Uncu, N. Zengin, “Effectiveness of first line treatment with modified docetaxel, cisplatin, 5-Fluorouracil in advanced gastric cancer”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B68. Köş, F.T., S. Aksoy, M.A. Şendur, Z. Arık, B. Civelek, N. Kandemir, N.Y. Özdemir, D. Uncu, N. Zengin, K. Altundağ, “Variations in tumor marker levels in metastatic breast cancer patients according to the tumor subtypes”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B69. Köş, F.T., S. Aksoy, M. Vural, M.A. Şendur, O. Yazıcı, B. Civelek, Z. Arık, N.Y. Özdemir, D. Uncu, N. Zengin, “24-hour blood pressure monitorization and assessment of endometrial function by flow mediated dilation in bevacizumab administred patients”,1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B70. Şendur, M.A., D. Uncu, N.Y. Özdemir, Ş. Yaman, O. Yazıcı, B. Civelek, H.İ. Yıldız, N. Zengin, “Prognostic features of patients with T1abN0M0 Breast Cancer”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B71. Yetişyiğit, T., E. Arpacı, A. Gök Durnalı, M. Küçüköner, F.T. Köş, Ö. Uysal Sönmez, S. Alıcı, T. Akman, R. Yıldız, Y. Günaydın, M. İnanç, U. Demirci, İ. Öztop, A. Işıkdoğan, A. Sevinç, D. Uncu, S. Şeber, N. Alkış, B. Öksüzoğlu, U. Yılmaz (ASMO Study Group), “The Impact Of Adjuvant Chemotherapy In Patıents Wıth Resected Synovıal Sarcoma: A Multıcenter Retrospectıve Analysis”,1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B72. Kos, F.T., B. Civelek, M.M. Seker, Z. Arik, S. Aksoy, D. Uncu, N. Ozdemir, N. Zengin, “Relatıonshıp Between Pancreas Cancer Overall Survival And The ABO BloodGroups”,1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B73. Alanlı, R., D. Uncu, İ. Özmen, N. Özdemir, S. Aksoy, N. Yılmaz, E. Abaylı, N. Zengin, “Clinical features and prognostic factors of 213 hepatocellular carcinoma patients”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B74. Çiltaş, A., D. Koca, U. Yılmaz, S. Büyükberber, O Eşbah, A. İnal , İ. Öztop, Ç. Binicier, T. Köş, M. İnanç, B. öksüzoğlu, A. Işıkdoğan, D. Uncu, M. Özkan, Ö.K. Yazıcı, O. Balakan, A. Sevinç, U. Coşkun, M. Benekli, “Retrospective Evaluation of Tolerability and Efficacy of Neo-adjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients (Multicentric Study of the Anatolian Society of Medical Oncology)”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B75. Karakaş, E., D. Uncu, E. Eskioğlu, B. Civelek, N. Zengin, “Prognostic Factors in Non-Small-Cell Lung Cancer Patients”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B76. Kucukoner, M., A. Isikdogan, C. Sener, U. Uyeturk, M. Seker, D. Tastekin, O. Tonyali, O. Balakan, O. K. Yazici, N. Ozdemir, A. Inal, M.A. Kaplan, A. Suner, D. Uncu, M. Turkeli, U. Demirci, Z. Urakci, M. Gumus, M.C. Boruban, B. Oksuzoglu, M. Benekli, “Primary gastric lymphoma: Study Of Anatolian Society Of Medical Oncology”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B77. Sevinç, A., M. Özkan, N. Büyükberber, A. Özet, F. Dane, B. Öksüzoğlu, A. Işıkdoğan, F. Özdemir, D. Uncu, M. Gümüş, N. Meydan, T. Evrensel, A. Yaren, O. Kara, S.B. Tekin, “The efficacy of Biosimilar and Original Filgrastim in patients with chemotherapy-induced neutropenia: National Observational Study” 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B78. Seker, M.M., S. Aksoy, N.Y. Ozdemir, D. Uncu, N. Zengin, “The retrospective evaluation of gastric cancer patients under age 40”, 1st Near East and Association of Medical Oncology Socieities (NEMA) Congress, İstanbul, Türkiye, 29 Nov-02 Dec, 2012
B79. Inal, A., A. Isikdogan, T. Kos, E. Algin, M. Gumus, M. Dikilitas, E.T. Elkiran, K. Helvaci, C. Geredeli, F. Dane, O. Balakan, A. Gok Durnali, H. Harputluoglu, G. Goksel, N. Ozdemir, S. Buyukberber, R. Yildiz, M.A. Kaplan, M. Ozkan, D. Uncu, “Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study”, Journal of Clinical Oncology, 29, (Post-Meeting Edition), abstr:e14534, ASCO Annual Meeting, Chicago, USA, 2011
B80. Babacan, N., S. Aksoy, B. Cetin, M.A. Kaplan, N. Ozdemir, T. Kos, U. Uyeturk, H. Karaca, D. Uncu, A. Isikdogan, M. Özkan, U. Coskun, M. Benekli, S. Buyukberber, N. Zengin,“Clinicopathologic characteristics of multiple primary cancers: 377 patients”, Journal of Clinical Oncology, 29, (Post-Meeting Edition), abstr:e19682, ASCO Annual Meeting, Chicago, USA, 2011
B81. Arslan, U.Y., O. B. Oksuzoglu, N. Ozdemir, S. Aksoy, N. Alkis, A. Gok Durnali, M. A. Kaplan, M. Gumus, V. Berk, D. Uncu, M. Baykara, D. Colak, U. Uyeturk, I. Turker, A. Isikdogan, “Outcome of operable male breast carcinoma: One hundred eighteen patients”, J Clin Oncol, 29, (suppl; abstr e11034), ASCO Annual Meeting, Chicago, USA, 2011
B82. Kaplan, M.A., A. Isikdogan, M. Gumus, U.Y. Arslan, C. Geredeli, N. Ozdemir, D. Koca, F. Dane, A. Suner, E.F. Elkiran, M. Kucukoner, M. Seker, K. Helvaci, T. Guler, D. Uncu, A. Inal, R. Yildiz R, “Childhood, adolescents, and young adults (age 25 and younger) colorectal cancer: A multicenter study.”, J Clin Oncol, 29, (suppl; abstr e14127), ASCO Annual Meeting, Chicago, USA, 2011
B83. Kucukoner, M., A. Isikdogan, M. Bilici, S.B. Tekin, D. Uncu, B. Cetin, F. Dane, M. Inanc, M.A. Kaplan, K. Cayir, S. Buyukberber, N. Ozdemir, N.S. Turhal, M. Ozkan, A. Inal, S. Aksoy, M. Benekli, “Adjuvant chemoradiotherapy in 450 patients with gastric cancer: The multicenter retrospective study”, J Clin Oncol, 29, (suppl; abstr e14623), ASCO Annual Meeting, Chicago, USA, 2011
B84. Ozdemir, N., S. Aksoy, M.B. Akinci, D. Uncu, B. Budakoglu, H. Abali, O.B. Oksuzoglu, N. Zengin, “Capecitabine/cisplatin doublet in patients with antracycline and taxane pretreated and HER2-negative metastatic breast carcinoma”,Journal of Clinical Oncology, 29, (Post-Meeting Edition), abstr: e11115, ASCO Annual Meeting, Chicago, USA, 2011
B85. Kos, F.T., S. Sezer, S. Aksoy, N. Ozdemir, B. Civelek, Z. Arık, S. Cihan, D. Uncu, M.B. Akinci, N. Zengin, “Helicobacter pylori seropositivity in colorectal cancer patients”, Annals of Oncology, abstr p0355, p:118, ESMO 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, June 22-25, 2011
B86. Kos, F.T., S. Aksoy, H. Odabas, N. Ozdemir, B. Oksuzoglu, D. Uncu, N. Zengin, “Adjuvant therapy for gall bladder and bile duct cancers: retrospective comparative study”, Annals of Oncology, abstr p0191, p:75, ESMO 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, June 22-25, 2011
B87. Aslan, N., H. Sayan, İ. Aytas, R. Habiboğlu, S.Z. Çakar, F. Çetinyokuş, D. Uncu, N. Zengin, “Concomitant chemoradiotherapy with weekly low dose cisplatin in patients with locoregionally advanced head and neck cancer: retrospective toxicity analysis”, Tri-Society Head and Neck Oncology Meeting, Singapore, September 1-3, 2011
B88. Odabas, H., N. Ozdemir, B. Oksuzoglu, H. Abali, F.T. Kos, N. Babacan, B. Civelek, D. Uncu, N. Zengin, “Eficacy and Safety of FOLFIRI-Bevacizumab for the Second-line Treatment of Metastatic Colorectal Carcinoma”,Annals of Oncology, 21, (suppl; abstr 684), 35th ESMO Congress, Milan, Italy, October, 2010
B89. Kos, F. T., D. Uncu, N. Ozdemir, B. Budakoglu, H. Odabas, N. Babacan, S. Cihan, M. Seker, B. Oksuzoglu, N. Zengin, “Comparison of CFF (cisplatin, 5-fluorouracil, folinic acid) and modified DCF (docetaxel, cisplatin, 5-fluorouracil) regimens in the first line treatment of metastatic gastric cancer”, Annals of Oncology (suppl 8), abstr 765, p:240, 35th ESMO Congress, Mılan, Italy, Oct 8-12, 2010
B90. Oksuzoglu, B., I. Turker, N. Yıldırım, G. Oksuzoglu, B. Budakoglu, D. Uncu, N. Zengin, “Smoking may contribute to development of gastric cancer in young Turkish man without family history”, IV Falk Gastro-Conference Proceedings Book, p:9, Freiburg, Germany, Oct 9-10, 2010
B91. Cihan, S., D. Uncu, N. A. Babacan, H. Odabas, N. Ozdemir, O. B. Oksuzoglu, N. Zengin, “Efficacy and tolerability of adjuvant modified FOLFOX-4 following chemoradioterapy for stage III rectum adenocarcinoma”, J Clin Oncol, 28(Suppl 15), abstr e14586, 46th Annual Meeting of American Society of Clinical Oncology, Chicago, USA, Jun 4-8, 2010
B92. Babacan, N.A., S. Cihan, D. Uncu, T. Kos, B. Civelek, H. Yildiz, N. Kandemir, T. Evrensel, N. Zengin, O. Manavoğlu, “The diagnostic and prognostic values of C-reactive protein procalcitonin, interleukin-8 and tumor necrosis factor-alpha in febrile neutropenic patients”, The 5th Asian Pacific Organization for Cancer Prevention Conference Proceedings Book, abstr P-037, İstanbul, Türkiye, April 3-7, 2010
B93. Uncu, D., F. Arpaci, M. Beyzadeoglu, A. Gunal, S. Surenkok, M. Ozturk, N. Ozdemir, A. Ozet, “Meningeal carcinomatosis: an extremely rare involvement of urinary bladder carcinoma”, The 5th Asian Pacific Organization for Cancer Prevention Conference Proceedings Book, abstr P-056, İstanbul, Türkiye, April 3-7, 2010
B94. Kos, F., D. Uncu, B. Oksuzoglu, N. Ozdemir, H. Odabas, M. Isik, B. Civelek, N. Babacan, N. Zengin, “Metastatic alveolar soft part sarcoma: an unusual long term survival”, The 5th Asian Pacific Organization for Cancer Prevention Conference Proceedings Book, abstr P-059, İstanbul, Türkiye, April 3-7, 2010
B95. Babacan, N., D. Uncu, O. Oksuzoglu, S. Cihan, H. Odabas, M. Seker, N. Kandemir, N. Ozdemir, B. Civelek, N. Zengin, “Primary central nervous system lymphoma in adults: a single center experience”, The 5th Asian Pacific Organization for Cancer Prevention Conference Proceedings Book, abstr P-234, İstanbul, Türkiye, April 3-7, 2010
B96. Yildiz, R., S. Buyukberber, N. Ozdemir, V. Berk, M. Kaplan, A. Uner, N. Alkis, U. Coskun, D. Uncu, O. Balaban, A. Isikdoğan, T. Yatisyigit, M. Ozkan, N. Zengin, M. Benekli, “The efficacy and toxicity of bevacizumab, combination chemotherapy regimens in metastatic colorectal cancer: a multicenter retrospestive study of Anatolian Society of Medical Oncology (ASMO)”, The 5th Asian Pacific Organization for Cancer Prevention Conference Proceedings Book, abstr P-259, İstanbul, Türkiye, April 3-7, 2010
B97. Odabas, H., N. Ozdemir, D. Uncu, O. B. Oksuzoglu, M. Isık, S. Cihan, M. Seker, N. Zengin, “Modified FOLFOX-4 or FOLFIRI-bevacizumab as first-line therapy of metastatic colorectal cancer”, 2010 Gastrointestinal Cancers Symposium Proceedings Book, abstr 412, p:161, Orlando, Florida, January 22-24, 2010
B98. Uncu, D., H. Abali, F. Ozmen, B. Oksuzoglu, N. Aslan, N. Ozdemir, B. Budakoglu, T. Guler, M. Tumoz, N. Zengin, “Adjuvant chemoradiotherapy with continious infusion 5-fluorouracil and bi-weekly cisplatin and infusional 5-fluorouracil for operated locally advenced gastric cancer”, Eur J Cancer, 7(Suppl), abstr 6522, p:368, Joint ECCO 15-34th ESMO Multidisciplinary Congress, Berlin, Germany, September 20-24, 2009
B99. Ozdemir, N.Y., H. Abali, B. Oksuzoglu, B. Budakoglu, D. Uncu, T. Guler, H. Odabasi, S. Cihan, N. Zengin, “The efficacy of modified docetaxel, cisplatin and 5-fluorouracilin advanced stage gastric carcinoma”, Eur J Cancer, 7(Suppl), abstr 6527, p:370, Joint ECCO 15-34th ESMO Multidisciplinary Congress, Berlin, Germany, September 20-24, 2009
B100. Arslan, U.Y., S. Tokluoglu, F.O. Onder, D. Uncu, U. Uyeturk, I. Turker, G. Celenkoglu, A. Ulas, N. Alkis, “Clinical outcomes and patient characteristics of triple negative breast carcinoma”, Eur J Cancer, 7(Suppl), abstr 5108, p:292, Joint ECCO 15-34th ESMO Multidisciplinary Congress, Berlin, Germany, September 20-24, 2009
B101. Ozet, A., D. Uncu, O. Kuzhan, F. Arpaci, M. Ozturk, S. Komurcu, B. Ozturk, “Evaluation of effect of oral capecitabine and oral cyclophosphamide in metastatic breast cancer patients with anthracyclin and taxan resistance”, J Clin Oncol, 26(Suppl), p:618, abstr e12028, 44th Annual Meeting of American Society of Clinical Oncology, Chicago, USA, May 30-June 3, 2008
B102. Yaman, E., S. Buyukberber, Y. Oner, U. Coskun, M. Akmansu, B. Ozturk, A.O. Kaya, R. Yildiz, D. Uncu, M. Benekli, “Temozolamide induced early necrosis in patients receiving temozolamide concomitant to radiotherapy”, Int J Radiat Oncol Biol Phys, 72 (Suppl), p:239, 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and Oncology, Boston, MA, USA, September 21-25, 2008
B103. Pamukcuoglu, M., B. Öksüzoğlu, H. Abalı, M. Akoğlu, F. Atalay, B. Budakoğlu, D. Uncu, N. Özdemir, T. Güler, N. Zengin, “Prognostic factors and clinicopathological characteristics of carcinoma of ampulla Vateri”, Proc. International Society of Gastrointestinal Oncology 2007 Conference, Philadelphia, September 27-29, abstr 209, 2007)
B104. Özmen, F., N. Yıldırım, B. Budakoğlu, D. Uncu, B. Öksüzoğlu, M.M. Özmen, N. Zengin, “The distribution of malignant tumors in elderly Turkish patients: a cross-sectional study”, Turkish Journal of Geriatrics, 9/1(Suppl 1) p-25, International Congress of Elderly Health, İstanbul, Turkey, 2006
B105. Ozdemir, N.Y., H. Abali, B. Oksuzoglu, B. Budakoglu, D. Uncu, T. Guler, N. Zengin, “Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast cancer progressing after anthracycline and taxane”, Annals of Oncology, 17 (Suppl 9), abstr 211, p:86, 31st ESMO Congress, Istanbul, Turkey, September 29-October 3, 2006
D. Ulusal hakemli dergilerde yayımlanan makaleler:
D1. Bölek Hatice, Yalçıner Merih, Sekmek Serhat, Ceylan Furkan, Akdoğan Orhun, Uncu Doğan, Yazıcı Ozan, Köksoy Elif Berna, Menopausal Status at Diagnosis is a Prognostic Indicator in Patients who are Operated for Uterine Carcinosarcoma. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Doi: 10.4274/atfm.galenos.2025.79058, 2025
D2. Hafızoğlu Emre, Sekmek Serhat, Bayram Doğan, Karahan İrfan, Algın Efnan, Bal Öznur, Uncu Doğan, When location meets biology: combined risk patterns drive outcomes in primary central nervous system lymphoma. Turkish Journal of Clinics and Laboratory, 3, Doi: 10.18663/tjcl.1761637, 2025
D3. Doğan Bayram , Öznur Bal , Alper Türkel , Serhat Sekmek , Emre Hafızoğlu , Berkan Karabuga , Mutlu Doğan , Efnan Algın , Doğan Uncu, Comparative Outcomes of Surgery and Chemoradiotherapy After Neoadjuvant Chemotherapy in Stage II–III Bladder Cancer, The European Resarch Journal, 160 - 172, 2025
D4. Doğan Bayram, Gökhan Uçar, Serhat Sekmek, Emre Hafızoğlu, İsmet Seven,Fahriye Tuğba Köş, Öznur Bal, Efnan Algın, Burak Civelek, Doğan Uncu, Prognostic Relevance of Tumor Localization in Patients with Synovial Sarcoma, Journal of Oncological Sciences 10: 17-24, 2024
D5. Aktürk Esen Selin, Hastürk Denizcan, Kahraman Seda, Ergün Yakup, Uçar Gökhan, Açıkgöz Yusuf, Hafızoğlu Emre, Bal Öznur, Algın Efnan, Köş Fahriye Tuğba, Şendur Mehmet Ali Nahit, Uncu Doğan, Clinicopathological Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients. Acta Oncologica Turcica, 55(2), 93-102, 2022
D6. Uçar Gökhan, Ergün Yakup, Aktürk Esen Selin, Aydın Özlem, Karahaliloğlu Ercan Aydın, Sarıcanbaz İrem, Uncu Doğan, Opere Pankreas Adenokanserli Hastalarda Kemoterapiye Kemoradyoterapi Eklemenin Katkısı. Dicle Tıp Dergisi, 47(4), 897-902, 2020
D7. Aktürk Esen Selin, Bal Öznur, Ergün Yakup, Açıkgöz Yusuf, Uçar Gökhan, Dirikoç Merve, Aydın İsak Özlem, Esen İrfan, Algın Efnan, Uncu Doğan, An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience. The Bulletin of Urooncology, 20(4), 258-263, 2020
D8. Ergün Y, Yıldırım Özdemir N, Yazıcı O, Uçar G, Açıkgöz Y, Bal Ö, Uncu D. Her2-pozitif lokal ileri meme kanserinde neoadjuvan trastuzumab sıralamasının patolojik tam yanıt üzerine etkisi theeffect of neoadjuvant trastuzumab treatmentsequence on pathologic completeresponse in HER2-positive locally advanced breastcancer. Bozok Tıp Dergisi. Haziran 2020;10(2):47-54. doi:10.16919/bozoktip.569169
D9. Neriman Sila Koc, Dogan Uncu, Selma Karaahmetoglu, Clinical features and prognostic factors in small bowel tumors: A retrospective evaluation of eighty cases, Annals of Medical Research, DOI: 10.5455/annalsmedres.2019.09.553, 27(1):277-82, 2020
D10. Acikgoz Y, Ergun Y,Ucar G, Dirikoc M, Uncu D. TheDifference in ClinicalandPrognosticFeaturesBetween De NovoandRecurrent Her2-Positive MetastaticBreastCancerPatients: Her2-positive metastaticbreastcancerpatients. ActaMedica [Internet]. 2019 Dec. 31 [cited 2025 Jul. 5];50(4):14-9. Availablefrom: https://actamedica.org/index.php/actamedica/article/view/395
D11. Ergün Y, Bal Ö, Doğan M, Uçar G, Dirikoç M, Açıkgöz Y, Uncu D. Thecomparison of oxaliplatin or irinotecan rechallenge treatment with regorafenib in thethird-linetreatment of metastatic colorectal cancer. Acta Haematol Oncol Turc. 2019 undefined;52(1):17-24. doi:10.5505/aot.2019.83703.
D12. Erdem, GU., M. Doğan, N. Demirci, Y. Bozkaya, D. Uncu, N. Zengin, “Mesanenin Transisyonel Hücreli Olmayan Kanserleri: Tek Merkez Deneyimi”, Acta Oncologica Turcica, doi: 10.5505/aot.2017.83007, 2017
D13. Algın, E., N. Özdemir, M. Doğan, G.U. Erdem, D. Uncu, T.K. Temuçin, Ö. Bal, N. Zengin, “Opere Gastrointestinal Stromal Tümörlü Hastaların Retrospektif Değerlendirmesi”, Acta Oncol Turcıca, 49, 86-90, 2016
D14. Kos, F.T., S. Sezer, O. Yazıcı, B. Civelek, A. Yıldız, S. Aksoy, N. Ozdemir, D. Uncu, M. Akıncı, N. Zengin, “Helicobacter Pylori Seropositivity of colon cancer”,Journal of Clinical and Analytical Medicine, DOI: 10.4328/JCAM.1826, 2013
D15. Alanlı, R., F.T. Köş, D. Uncu, O. Yazıcı, N. Özdemir, S. Aksoy, N. Yılmaz, E. Abaylı, N. Zengin, “Hepatosellüler kanserli hastaların klinik özellikleri ve prognostik faktörleri: tek merkez deneyimi”, Türk Onkoloji Dergisi, 28, 143-149, 2013
D16. Şeker, M.M., S. Aksoy, N.A. Babacan, T. Kacan, N.Y. Özdemir, D. Uncu, N. Zengin, Renal epithelioid angiomyolipoma: Sucesfully treated with chemotherapy, Acta Medica, 2, 35-37, 2013
D17. Köş, F.T., D. Uncu, N. Yıldırım, B. Öksüzoğlu, N. Babacan, Ş. Cihan, N. Zengin, “Adrenal kortikal karsinom: tek merkez deneyimi”, Türkiye Klinikleri J Endocrin, 6, 1-5, 2011
D18. Uncu, D., B. Öksüzoğlu, B. Budakoğlu, S. Günce, N. Özdemir, T. Güler, N, Zengin, “Primary squamous cell carcinoma of the breast”, Turkish Journal of Cancer, 39, 26-27, 2009
D19. Uncu, D., H. Abalı, N. Özdemir, B. Budakoğlu, T. Güler, B.Ç. Öksüzoğlu, N. Zengin, “Non-Hodgkin lenfomada prognostik faktörler”, Uluslararası Hematoloji-Onkoloji Dergisi, 16, 27-31, 2006
D20. Uncu, D., N. Özdemir, Ş. Karakan, B.Ç. Öksüzoğlu, N. Zengin, “Primer ekstranodal lenfomalar: Klinik özelliklerinin nodal lenfomalarla karşılaştırılması”, Uluslararası Hematoloji-Onkoloji Dergisi, 15, 63-67, 2005
D21. Karakan, Ş., B. Öksüzoğlu, D. Uncu, N. Yıldırım, B. Budakoğlu, M. Küçükazman, H. Genç, S. Akdur, N. Zengin, “Yumuşak doku Ewing sarkomu ve primitive nöroektodermal tümörlü erişkin olguların retrospektif değerlendirilmesi”, Uluslararası Hematoloji-Onkoloji Dergisi, 14, 14-19, 2004
D22. Okumuş O., D. Uncu, D. Yazılıtaş, B. Budakoğlu, N. Yıldırım, S. Akdur, “Meme kanserli hastalarda metastaz durumunun diğer parametrelerle karşılaştırılması”, Sağlık ve Toplum, 4, 42-47, 2002
D23. Yıldırım, N., D. Yazılıtaş, S. Akdur, D. Uncu, “Perikardiyal tamponad ve tıkanma ikteri kliniğine sahip bir non-Hodgkin lenfoma olgusu”, Sağlık ve Toplum, 2, 72-74, 2002
D24. Bozarslan, K., D. Uncu, D. Yazılıtaş, M. Küçükazman, H.H. Genç, S. Akdur, “Kolorektal kanserlerde CEA düzeyinin metastaz durumu ve prognoz ile ilişkisi”, Ankara Numune Hastanesi Tıp Dergisi, 41, 1-6, 2002
D25. Özkan, E., D. Yazılıtaş, N. Yıldırım, O. Bağdatoğlu, D. Uncu, H.H. Genç, S. Akdur, “Non-Hodgkin lenfomalı hastalarda serum laktat dehidrogenaz ve beta2 mikroglobulin düzeyleri ile diğer parametrelerin karşılaştırılması”, Ankara Numune Hastanesi Tıp Dergisi, 40, 33-37, 2001
D26. Çeliker, İ.M., D. Yazılıtaş, N. Yıldırım, D. Uncu, B. Budakoğlu, H.H. Genç ,S. Akdur, “Primeri bilinmeyen metastatik kanserlerin klinik ve histopatolojik prezentasyonu”, Ankara Numune Hastanesi Tıp Dergisi, 40, 27-32, 2001
Sık Sorulan Sorular
Prof. Dr. Doğan Uncu ile nasıl iletişime geçerim?
Prof. Dr. Doğan Uncu ile iletişime geçmek için bu telefon numarasını ara: +908504740468
Prof. Dr. Doğan Uncu için nasıl randevu alabilirim?
Prof. Dr. Doğan Uncu için online veya telefonla randevu alabilirsin.
Prof. Dr. Doğan Uncu hangi hastanede/klinikte çalışıyor, iletişim bilgileri nedir?
Prof. Dr. Doğan Uncu, İstinye Üniversitesi Gaziosmanpaşa Hastanesi bünyesinde çalışmaktadır. Uzmanının iletişim bilgilerine profilinden ulaşabilirsiniz
Prof. Dr. Doğan Uncu kimdir, hangi uzmanlık alanında hizmet veriyor?
Prof. Dr. Doğan Uncu, Dahiliye - İç Hastalıkları, Tıbbi Onkoloji uzmanıdır. Kanserde Risk Faktörleri, Cilt Kanseri, Prostat Kanseri, Lenfomalar, Nöroendokrin Tümörler, Tiroid Kanseri, Hormon Tedavileri, Akciğer Kanseri, Jinekolojik Kanserler, Larinks Kanseri alanlarında hizmet veriyor.
Prof. Dr. Doğan Uncu muayene ücreti ne kadar?
Prof. Dr. Doğan Uncu muayene ücreti için +908504740468 numaralı randevu hattı ile iletişime geçin.